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Transformation of BALB/c-3T3 Cells:
IV. Rank-Ordered Potency of 24 Chemical
Responses Detected in a Sensitive New Assay
Procedure
by Edwin J. Matthews,1 Judson W. Spalding, and
Raymond W. Tennant
Thisreport introduces an improvedmethodofdetectingchemical-induced morphologicaltransformation of
A-31-1-13 BALB/c-3T3 cells. The new procedure uses an increased target cell population to assess chemical-
induced damage by increasing the initial seeding density and by delaying the initiation time of chemical
treatment. Furthermore, anewlydeveloped co-culture clonal survival assaywasusedto select chemical doses
for the transformation assay. This assay measured the relative cloning efficiency (RCE) of chemical
treatments in high-density cell cultures. In addition, transformation assay sensitivity was enhanced through
the use ofimproved methodsto solubilize manychemicals. From agroupof24 chemicals tested in at leasttwo
trials, clear evidence ofchemical-induced transformation was detected for 12 chemicals (aphidicolin, barium
chloride-2H20, 5-bromo-2'-deoxyuridine, C.I. direct blue 15, trans-cinnamaldehyde, cytosine arabinoside,
diphenylnitrosamine, manganese sulfate-H20, 2-mercaptobenzimidazole, mezerein, riddelliine, and 2,6-
xylidine); 2 chemicals had equivocal activity [C.I. direct blue 218 and mono(2-ethylhexyl)phthalate], 9
chemicals were inactive [carisoprodol, chloramphenicol sodium succinate, 4-chloro-2-nitroaniline, C.I. acid
red 114, isobutyraldehyde, mono(2-ethylhexyl)adipate, sodium fluoride, and 12-O-tetradecanoylphorbol-13-
acetate), and 1 chemical had an indeterminate response (2,6-dinitrotoluene). All positive responses were
detected in the absence of an exogenous activation system and exhibited significant activity at two or more
consecutive doses.Thisreport alsopresents amathematical methodthatusest-statisticsforrank-orderingthe
potency ofchemical-induced transformation responses. This model detects sensitivity differences in experi-
ments used to evaluate chemical-induced transformation. Furthermore, it provides a method to estimate a
chemical's transformation response in terms of the historical behavior of the assay, as well as its future
activity. The most active ofthe 24 chemicals was mezerein, andthe least active chemical was diphenylnitrosa-
mine.
Introduction
The BALB/c-3T3 cell transformation assay design rec-
ommended by government agencies (1) and scientific com-
mittees (2) has remained essentially unchanged from the
method first described by Kakunaga (3). Although this
protocol has been demonstrated to detect some carcino-
genic chemicals (4,5), it has a lowsensitivity (4) for detect-
ing the diverse group of chemicals screened in the NTP/
NCI rodent bioassay (6-9).
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The low sensitivity ofthe standard BALB/c-3T3 trans-
formation assaymethod has been reproduced in this labo-
ratory. In 1983 and 1984, using the recommended method
(1-3) we screened 55 coded chemicals on an interagency
contract with the National Institute of Environmental
Health Sciences and the Environmental Protection
Agency. This group ofchemicals contained 2 model chemi-
cals and 53 other chemicals thatwere being considered at
thattime forevaluation intherodentbioassay. Theresults
of our investigations have been presented in abstract
format (10), are summarized in Appendix B, and have
confirmed the low sensitivity of the standard assay
method.
At the onset of this program, we investigated many
different experimental parameters to determine those
that affected the sensitivity of the BALB/c-3T3 cells to
detectchemical-induced transformation. This report sum-
marizes ourfindings and describes anewassayprocedure
that was designed to enhance sensitivity for detectingMATTHEWS ET AL.
chemical-induced transformation. The present investiga-
tion reports the activities of 24 chemicals that have been
tested using the new transformation protocol. This meth-
odology has been also used to test the activities of an
additional 166 test chemicals (11,12).
Materials and Methods
Cell Culture
Theinvestigations inthisreportusedthe1-13 cloneofA31
BALB/c-3T3cells (13,14).Thematerialsandmethodsusedto
culture the cells have been previously reported in detail (15)
and are summarized in part I ofthese investigations (17).
Standard Clonal Survival Assay
The standard clonal survival assay was used to a)
estimate the cytotoxic activity ofa test chemical, b) select
treatment doses for the preliminary co-culture clonal sur-
vival assay described below, c) assess the reproducibility
ofthe chemical-induced cytotoxic responses, and d) deter-
mine therelative shiftin testchemical cytotoxic responses
between high- and low-density cell cultures. The standard
clonal survival assay used low-density cultures ofBALB/
c-3T3 cells and was conducted according to our modifica-
tion (15) of the method first described by Kakunaga (3).
Briefly, 200 WT cellswere seeded in either 60-mm culture
dishes(CorningScienceProducts,Corning, NY) or25-cm2
culture flasks (Corning). The test chemical treatment
doses were applied to triplicate cultures for 48 hr begin-
ning2 days afterseeding. Treatmentswereterminated by
removal of the chemical treatment medium, washing the
culture vessels twice with Hank's balanced salt solution
(HBSS; Quality Biologicals, Gaithersburg, MD) and feed-
ingwith culture medium. After a total culture period of8
days, thevesselswerewashedwithHBSS,fixedwith100%
methanol, stained with 10% Giemsa in tap water, and
colonies ofcells were hand tabulated using an illuminated
light box.
Co-culture Clonal Survival Assay
The co-culture clonal survival assay was used to select
chemical treatment doses for transformation assays,
assess the reproducibility of chemical-induced cytotoxic
responses, and verify that the test chemical and positive
control treatment doseswere cytotoxic inthetransforma-
tion assay. The procedure used for the co-culture clonal
survival assay has been previously reported in detail
(11,13) and is summarized in part III ofthis series (17).
Calculation ofCytotoxic Response
The cytotoxic responses of chemicals were compared
usingthe concentration in millimoles that resulted in 50%
RCE of chemical-treated cells relative to untreated cul-
tures. This LD50 treatment dose was extrapolated from
graphs of dose-related changes in cytotoxic responses of
the chemical detected in the co-culture and the standard
clonal survival assays.
Transformation Assay
The BALB/c-3T3 cell transformation assay design in
this study used our modification (15) of the method first
described by Kakunaga (3). The transformation assay
culture vessels were seeded with 3.2 x 104 WT cells/
vessel. The positive control and test chemical treatment
sets had 20 60-mm culture dishes (18 25-cm2 culture
flasks), and the negative control (NC-1) had 40-80 60-mm
culture dishes (36-72 culture flasks). The positive control
foreachassaywasbenzo[a]pyrene (BaP; Sigma,St. Louis,
MO), anditwastested atdoses of0.200 and 0.0633 [Lg/mL
to assess the reproducibility of dose-related increases of
BaP-induced cytotoxic and transforming activities (17). A
total ofthree to six test chemicals were included in each
transformation experiment, and each chemicalwas tested
atfourtreatment doses in two ormore independenttrials.
The four doses were chosen based on chemical-induced
cytotoxic activities detected in the co-culture clonal sur-
vival assay. These doses attempted to cover a range of
cytotoxic responses of10-100% RCE. Test chemical, posi-
tive control, and solventcontroltreatments ofcell cultures
were performed as described for the standard clonal
survival assay. Transformation assayculturevesselswere
fed biweekly with minimal culture media a total of seven
times over3.5weeks, andtheassaywasterminatedaftera
total culture period of28 days.
The transformation assays in this investigation also
included additional components to extend the information
obtained from each experiment. For example, each trans-
formation experiment had concomitant standard and co-
culture clonal survival assays, and the purpose of using
both assays is explained above. In addition, the transfor-
mation assayincluded seedingdensitycontrols (NC-2 and
NC-3) of 1.0 x 104 cells/vessel and 3.2 x 103 cells/vessel,
respectively. These controls were used to detect crowding
effects and preexisting transformed variants that were
occasionallydetectedintransformationassaysusingwild-
type (WT) BALB/c-3T3 cells (16). Finally, because each
chemical was tested in two or more trials, one active test
chemical was used as a second positive control for each
experiment and tested along with test chemicals of
unknown activity.
nTansformation Assay Acceptance and
Evaluation Criteria
Single Ransformation Experiment. In this investiga-
tion, a test chemical's activity in a single transformation
experiment was evaluated as having one of four possible
transformation responses: sufficientpositive (SP), limited
activity (LA), sufficient negative (SN), and limited nega-
tive (LN). An SP transformation response required that a
test chemical response was statistically significant at two
ormoreconsecutive treatmentdoses. Oneofthetwo doses
must have been significant at the 99% confidence level
(p<0.01), buttheseconddosecould havebeensignificantat
either the 99% or the 95% confidence level (0.05<p.O0.01).
In addition, the SP response must have included a dose-
related increase in activity relative to the experiment
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solvent control. In contrast to the SP response, a LA
transformation response required that a test chemical
response was statistically significant at either one treat-
ment dose alone at the 99% confidence level or at two
consecutive doses at the 95% confidence level.
An SN transformation response required that a test
chemical response did not have a statistically significant
increase in transformation responses at any of the four
treatment doses. Furthermore, one or more ofthe chemi-
cal treatment doses induced a significant cytotoxic
response. Asignificant cytotoxic response is a test chemi-
cal treatment dose that resulted in 50% RCE detected in
the co-culture clonal survival assay.
An LN transformation response occurred under two
different circumstances. First, the four test chemical
treatment doses did not induce a statistically significant
transformation response; however, in contrast to an SN
transformation response, thetestchemicaltreatments did
have significant cytotoxic responses. Therefore, higher
concentrations of the test chemical could have induced a
significantcytotoxic response,andthiscouldhaveresulted
in a statistically significant transformation response. Sec-
ond, the test chemical had the equivalent ofan SN trans-
formation response; however, the positive control for the
transformation experiment was inactive and did not
induce a statistically significant response.
Twvo or More 1Jansformation Experiments. When a
test chemical is evaluated in two consecutive experiments,
itscumulative response intheseexperimentsis arbitrarily
described in this investigation as either active, weakly
active, inactive, or indeterminate. Test chemicals were
evaluated as active when two different combinations of
transformation responses were obtained: a) two SP
responses and b) an SP and an LA response. A weakly
active test chemical occurred when the two consecutive
responses were an SP and an SN. Conversely, test chemi-
cals were evaluated as inactive when three different com-
binations of transformation responses were obtained: a)
two LAresponses; b) two SNresponses; and c) an LAand
anSNresponse.
Test chemicals with indeterminate activity occurred
under four different combinations of transformation
responses: a) two LN responses; b) an LA and an LN; c)
an SN and an LN response; and d) an SP and an SN
response. Thus, testchemicals with acombined SP and an
SN response in two consecutive trials could have been
evaluated as either weakly active or indeterminate. Ifthe
mean t-statistics of the two experiments are not signifi-
cantly different from one another, then the chemical was
evaluated as having been weakly active in the two experi-
ments(see"StatisticalAnalysis andMathematicalModel,"
below). Conversely, if the mean t-statistics of the two
experiments are significantly different from one another,
the test chemical was evaluated as having had an indeter-
minate activity.
Test chemicals evaluated as having an indeterminate
activity must be tested in a third experiment before they
can be reevaluated as either active or inactive in the
BALB/c-3T3 transformation assay. However, a few test
chemicals such as titanium dioxide (12) were noncytotoxic
at treatment doses > 5-fold higher than their solubility
limit in culture medium supplemented with pluronic F68.
Because cytotoxic responses could not be achieved with
thistypeofchemicalatanyreasonabletreatmentdose,the
response of this test chemical was evaluated as having
been inactive with an indeterminate activity.
Evaluation ofTransformed Foci
Spontaneous and BaP-induced transformation re-
sponsesofthisclone ofBALB/c-3T3 cellshavebeenshown
toincludeacontinuumoftype ,IL,andIIIfociofdifferent
sizes (16,18). The number of type III foci were identified
microscopically accordingtopublishedcriteria(2-3,19,20).
Type III foci . 2 mm in diameter had three phenotypic
properties,includingpilingandoverlappingofcells,disori-
entation ofcells attheperipheryofthefocus, and invasion
oftransformed cells into a contact-inhibited monolayer of
WT cells.Type I and II fociofBALB/c-3T3 cellswere also
recorded and appeared in many different sizes, but they
lacked the combination of three phenotypic properties
previously noted for the type III transformed focus. This
reportwillpresentonlythetype IIIfocus dataforthetest
chemicals.
Handling ofTest Chemicals
Manychemicals in this investigation had physicochemi-
cal properties that could have potentially interfered with
them being adequately tested in the BALB/c-3T3 cell
transformation assay (see Table 1). Therefore, procedures
were developed to ensure that all test chemicals would be
consistently and adequately evaluated.
pH. For example, all test chemicals were evaluated at a
physiologicpH.Thus, stocksolutionsoftestchemicalsthat
alteredthephysiological pH range ofculture medium (i.e.,
pH7.2-7.4)wereneutralizedwithconcentratedstocksolu-
tions ofeither hydrochloric acid (1 or 5 N HCl) or sodium
hydroxide (1 or 5 N NaOH) before their use as dosing
solutions. In addition, all test chemical dosing solutions
and controls were prepared in a 5-fold concentrated form
and rapidly administered in 1 mL of medium to culture
vessels containing 4 mL of medium. This procedure
avoided wide fluctuations of the pH of medium in the
culture vessels during dosing.
Volatility All liquid chemicals have a vapor pressure at
37°Candarevolatileatthistemperature.Therefore,allliquid
chemicals weretestedin closedcultureflasks to ensurethat
thechemicaltreatmentdosesremained constantthroughout
the48-hrtreatmentperiod andwereinequilibriumwiththe
aqueous culture medium environment.
ChemicalReactivity* Some test chemicals react with
strong acids or strong bases (i.e., trans-cinnamaldehyde,
2,6-dinitrotoluene, and sodium fluoride) or with hypoc-
horites (2,6-xylidine; Table 1). These problems were ofno
concern because thesereactive chemicals were notusedin
the assay procedures. In addition, 21 test chemicals that
were not included in this investigation were observed to
pit, oretch,theplasticculturevessels atthe samerangeof
treatmentdosesusedto assesscytotoxicactivity(12).This
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Table L Summary ofcytotoxic responses of24 test chemicals detected in a co-culture clonal survival assay.
Molecular Physiochemical properties Cytotoxic
Chemical CAS no. weight PS SV TP responses, mMa
Aphidicolin 38966-21-1 338.5 S DCF ts 0.000414
Barium chloride-2H20 10326-27-9 244.0 S C sp 1.70
5-Bromo-2'-deoxyuridine 59-14-3 307.4 S DCF Is, ts 0.0612
Carisoprodol 78-44-4 260.0 S DCF 3.33
Chloramphenicol sodium succinate 982-57-0 445.2 S C 5.62
4-Chloro-2-nitroaniline 89-63-4 172.5 S DCF 0.638
C. I. Acid red 114 6459-94-5 830.0 S DCF 0.719
C. I. Direct blue 15 2429-74-5 996.9 S CF ls, 2.68
C. I. Direct blue 218 28407-37-6 1087.9 S CF 0.448
trans-Cinnamaldehyde 14371-10-9 132.2 L DCF ls, ts, oa, rab, vol 0.0535
Cytosine arabinoside 147-94-4 279.7 S DC ts 0.000601
2,6-Dinitrotoluene 606-20-2 150.0 S DCF ts, rab 2.03
Diphenylnitrosamine 86-30-6 198.22 S DCF ls 0.479
Isobutyraldehyde 78-84-2 72.10 L DCF ts, oa, vol 4.37
Manganese sulfate-H20 10034-96-5 246.5 S CF apH 0.100
2-Mercaptobenzimidazole 583-39-1 150.0 S DCF ts 3.25
Methdilazine-HCl 1229-35-2 296.0 S DCF ls 0.0314
Mezerein 34807-41-5 654.0 S DCF 0.0306
Mono(2-ethylhexyl)adipate 4337-65-9 258.42 L DCF bpH, ts 1.12
Mono(2-ethylhexyl)phthalate 4376-20-9 278.4 S/L DCF bpH, ts 1.04
Riddelliine 23246-96-0 349.0 S CF bpH, hac, ts, oa 4.78
Sodium fluoride 7681-49-4 42.0 S C apH, Is, rab 2.31
12-O-Tetradecanoylphorbol-13-acetate 16561-29-8 616.0 S DC ts 0.0145
2,6-Xylidine 87-62-7 121.2 L DCF vol, ts, rhc 4.86
Abbreviations: CAS no., Chemical Abstract Service registrynumber; LD50, lethal dose for 50% ofthe cells; PS, physical state, S, solid, L, liquid; SV,
solvent vehicle; D, dimethyl sulfoxide; C, culture medium; F, pluronic F68; A, acetone, E, ethanol; TP, technical problems; ls, light sensitive; ts,
temperature sensitive, oa, oxidized in air; vol., volatile at37°C; rac, reacted with acids; rab, reactedwith bases; apH, caused acid pH, bpH, caused basic
pH, hac, hydrolyzed under alkaline conditions; rhc, reacted with hypochlorites; and sp, solubility problem.
aThe co-culture clonal survival assay design used to detect the cytotoxic response ofthe test chemical is described in Materials and Methods. The
cytotoxic responsesofchemicalsinindividualexperiments aresummarizedintermsofthemillimolarLD50treatmentdosethatresultedin50%survival
ofthe chemically treated cells relative to the survival ofuntreated or solvent control treated cell cultures. The LD50 cytotoxic responseis an average of
twoormoreexperimentswiththechemical. Themolecularweightofeach chemicalisprovided sothattreatmentdoses canbeconvertedfrommMto ,ug/
mL. For example, based on the molecular weight of338.5 for aphidicolin, the LD50 detected for aphidicolin was about 0.000414 mM or 0.146 [Lg/mL.
chemical reaction occurred within minutes after the sol-
uble chemical treatment doses were added to culture
vessels; thus, the amount of test chemical in the culture
medium was time dependent. Furthermore, the relative
time the chemical had to interactwith the target cell was
reduced to minutes compared to the standard 48-hrtreat-
ment time. These chemicals had to be tested in achemical
resistant culture vessel. In this investigation, iso-
butyraldehyde reacted with plastic; however, this problem
was not observed to occur when the chemical was com-
pletely dissolved in culture medium supplemented with
pluronic F68.
Solubility. Approximately 65% of200 chemicals tested
in this program were relatively insoluble in water.
Although many chemicals that were insoluble in water
were soluble in one or more organic solvents such as
acetone, dimethylsulfoxide (DMSO), and ethanol, these
organic solvents did not help increase the relative sol-
ubility of the test chemicals in culture medium. To over-
come this problem, the test chemical was dissolved in the
appropriate organic solvent at a high concentrations and
than dispersed in medium supplemented with a non-
cytotoxic, nonionic surfactant pluronic F68 at 1.25% w/v
(11,21). The final concentration of the solvent vehicles
applied to cell cultures was low and limited to < 0.2% v/v
organic solvent and 0.25% w/v pluronic F68. Using this
procedure, many test chemicals were completely soluble,
or they formed a stable emulsion or a fine particulate
suspension.
Test Chemicals
The following test chemicals in this investigation were
supplied by Radian Corporation (Houston, TX), which
maintained the chemical repository for the National Tox-
icology Program: barium chloride-2H20; carisoprodol;
chloramphenicol sodium succinate; 4-chloro-2-nitro-
aniline; C.I. acidred114; C.I. directblue15; C.I. directblue
218;trans-cinnamaldehyde;isobutyraldehyde;manganese
sulfate-H20; 2-mercaptobenzimidazole; methdilazine-
HCI; mezerein; mono(2-ethylhexyl)adipate; mono(2-
ethylhexyl)phthalate; riddelliine; sodiumfluoride; and2,6-
xylidine. Aphidicolin and 5-bromo-2'-deoxyuridine were
purchased from Sigma (St. Louis, MO), and cytosine ara-
binoside and diphenylnitrosamine were purchased from
Aldrich (Milwaukee, WI). 12-0-Tetradecanoylphorbol-13-
acetatewaspurchasedfromConsolidated Midland Corpo-
ration. 2,6-Dinitrotoluene was obtained from Midwest
Research Institute.
StatisticalAnalyses andMathematical Models
Mathematical Rtansformation of Focus Data. In a
typicaltransformation experiment, the normal expression
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of the transformed cell phenotype included a few vessels
that appeared randomlywith large numbers oftype I, II,
and III foci in control and in chemical-treated culture
vessels (15-16,18,22). These vessels resulted in a distribu-
tion offoci/vessel that was abnormal (15-16,22), and they
were notstatistical outliers relativetothehistorical behav-
ior of the assay (23). Several mathematical transforma-
tions (24) were investigated, and the historical database
forthe assaywas found notto deviate significantly from a
normal distribution of foci/vessel when the data were
transformed to the log1o (16). Thus, before any statistical
analyses of the data, one was added to the number of all
scoredvessels toavoid computational instabilitieswiththe
log transformation, and the resulting total was converted
to its log1o equivalent value.
Significance ofTransformation Responses. The sta-
tistical significance ofchemical transformation responses
was determined by computer in three steps using SAS
software (25). First, an analysis ofvariance oftestchemi-
cal and control transforming activities was performed on
log1odatausingtheF-test(18,24). Second, thesignificance
ofdifferences ofcontrolandchemical-inducedtransforma-
tion responses was calculated using modifications of the
Student's t-test, one assuming equal variance (EV)
between the control and the chemical response and the
otherassumingunequalvariance (UV) (25). Useofthe EV
or UV model was distinguished by an F-test for hetero-
geneousvariance; significant departure (i.e.,p<O.05) sug-
gested use ofthe UV model. Third, the probability ofthe
individual test chemical treatment transformation
response exhibiting a significant departure from no effect
was determined using the appropriate UV or EVt-statis-
tic.
Methods forRank-Ordering Test Chemical Transfor-
mation Responses. Test chemical transformation re-
sponseswere rank ordered onthebasis ofthe significance
of their activity in the transformation assay. The signifi-
cance ofthe test chemical response varied proportionally
to the magnitude ofthe t-statistic, and the t-statistic was
independent of the absolute spontaneous transformation
responseofthesolventcontrol (refertoAppendixAforthe
t-statistics of24chemicaltransformationresponses).Vari-
ability among the mean spontaneous control transforma-
tionresponsesinindividual experimentsprecludedtheuse
of mean chemical-induced transformation responses for
this purpose. The average significance of each chemical
transformation response, or mean t-statistic, was calcu-
latedbyaveragingthe t-statistics ofthe fourtestchemical
(ortwopositivecontrol) treatmentdoses.Treatmentdoses
with <5% RCE and incomplete monolayers were deleted,
and negative t-statistics were arbitrarily assigned the
value ofzero. This mean t-statistic wasused to rank order
chemical transformation responses in individual experi-
ments.Asimilarmethodhasbeenemployedusingz-statis-
tics from nonparametric statistical tests (26). The test
chemical activity in two or more experimental trials was
assessed using a weighted rank t-statistic. It was calcu-
lated using all the t-statistics for test chemical treatments
in two or more experimental trials. Examples of these
calculations are provided in the Results.
StatisticalSensitivity versusSpontaneous Transfor-
mationResponses. Themedian spontaneous transforma-
tion response for110 experiments conducted over a2-year
period has been reported (16), and it was highly variable.
Variability ofspontaneous responses was correlated with
the use of different ampules of cells from the same
cryopreserved pool (16), and variable responses directly
affected the ability oftransformation assays to discrimi-
nate significant positive control BaP-induced responses
(18). Experimentswith aspontaneousresponselowerthan
the median activity had a lower statistical sensitivity to
detect test chemical responses. The statistical sensitivity
was estimatedbycalculatingtheratio oftexP./tmed . Thisis
the t-statistic ofanindividual experiment [texP-] dividedby
the t-statistic ofthe median experiment [tmed.]. Thus, the
statistical sensitivity was equal to the ratio of the XexP./
SEexp. divided by Xmed./SEmed.. The Xexp. and the Xmed.
are the mean experimental and median spontaneous
responses, andtheSEexP andtheSEied arethestandard
errors ofthe mean experimental and median spontaneous
transformation responses. Using the magnitude of this
ratio, 110 independent experiments were rank-ordered
from the highest to the lowest in terms of statistical
sensitivity (16).
The ranking of spontaneous transformation responses
revealed that a) 10.9% (12/110) of the experiments had a
significantly high statistical sensitivity, b) 89/110 (80.9%)
of the experiments had statistical sensitivities that were
not significantly different from the median experiment
statistical sensitivity, and c) 8.2% (9/110) of the experi-
ments had asignificantlylowstatistical sensitivity(16).An
experiment with a significantly low statistical sensitivity
had a spontaneous response thatwas less than about 0.20
type IIIfoci/vessel, and anexperimentwith asignificantly
high statistical sensitivityhad a spontaneous transforma-
tion response greater than about 2.5 type III foci/vessel
(16).
Detection Sensitivity versus BaP TRansformation
Responses. BaP induced highly significant transforma-
tion responses in109/110 experiments in this investigation
(18). Nevertheless, themagnitudeoftheBaPresponsewas
variable among these experiments, and a portion of this
variabilitycorrelatedwiththe serumlotused andwiththe
aliquot ofcells used to initiate the transformation experi-
ments (18). Because certain serum lots reduced both the
BaPtransformation response andthe cytotoxicity ofBaP,
it was not considered to be a serious problem. The serum
effect could be overcome by adjustment ofthe BaP treat-
ment dose concentrations and testing BaP at comparable
levels ofcytotoxicity. Thus, the serum-dependenteffect on
cytotoxic responses should not have affected the activities
of test chemicals tested at cytotoxic treatment doses in
this investigation. In contrast, variability among BaP
responses was not correlated to the source ofBaP orwith
the passage level ofcultures (18).
Becauseallcellsinthisinvestigationwereobtainedfrom
one cryopreserved pool of cells, ampule-dependent BaP
transformation responses demonstrated that capacity to
detect chemical-induced transformation was not equal in
each experiment (15). Therefore, BaP responses were sta-
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tistically compared to the median experiment, and the 110
experiments were rank ordered according to their detec-
tion sensitivity for BaP (18). The ranking of the experi-
mentsrevealedthat25.5% (28/110)had asignificantlyhigh
detection sensitivityfor BaP, 48.2% (53/110) ofthe experi-
ments had a detection sensitivity comparable to the
median experiment, and 26.4% (29/110) ofthe experiments
had a significantly low detection sensitivity.
Effect of Statistical Sensitivity on Detection Sen-
sitivity for BaP. Experiments with normal or signifi-
cantly high statistical sensitivity had normal detection
sensitivity for BaP (18). Thus, these two groups ofexperi-
ments were predicted to have a normal capacity to detect
chemical-induced transformation responses, and theyhad
actual rankt-statisticsthatwere accurate estimates ofthe
test chemical's activity. Therefore, these two groups of
experiments had actualrankt-statisticsthatwereequal to
the estimated rank t-statistic.
In contrast, experiments with significantly low statisti-
cal sensitivity have been demonstrated to affectthe detec-
tionsensitivityfor BaP(18). Forthenineexperimentswith
significantlylowstatistical sensitivity, noexperiments had
significantly high detection sensitivity for BaP and six of
nine experiments had significantly low detection sen-
sitivity for BaP. Therefore, these experiments had a high
probability ofunderestimating the activity oftest chemi-
cals, as well as underestimating the rank t-statistic.
To compensate for the diminished sensitivity to detect
chemical-induced transformation, the rank t-statistic is
multiplied by a correction factor to obtain an estimated
rankt-statistic. Thecorrectionfactor wasequal tothe sum
total rank ordernumbers forthe testchemical experimen-
tal statistical sensitivity and detection sensitivity for BaP
divided bythe median number ofexperiment (i.e., 55). For
example, the most active test chemical, mezerein, had
statistical sensitivities for spontaneous transformation
responses of 75 and 8*/110 for experiments 59 and 95,
respectively, and detection sensitivities for BaP of 76 and
29/110 for the same experiments (Table 2). Therefore, the
averagerankorderofthetwoexperiments was47.0(i.e., 75
+ 8 + 76 + 29/4 = 47.0). For a total of110 experiments,
the median experiment has an automatic average rank
orderof55.0 (i.e., 110/2 = 55.0). Thus, thecorrectionfactor
for the experimental sensitivity to detect chemical-
induced transformation was 47.0/55.0 or 0.855. Experi-
ments 59 and 95 had a combined statistical sensitivityand
detection sensitivity that were slightly above the median
of 55.0. Because the correction factor is less than 1, the
actualrankt-statisticisnotcorrected and wasleftequalto
the estimated rank t-statistic. Ifthe correction factor had
been more than one, the actual rank t-statistic would have
been multiplied by the correction factor to obtain the
estimated rank t-statistic. A justification for this correc-
tion factor has been reported (18).
Results
Cytotoxic Responses of 24 Test Chemicals
The cytotoxic responses of 24 test chemicals were
assessed using standard and co-culture clonal survival
assays. The cytotoxic response data derived from the co-
culture assay was most important because these data
measured clonal survival of chemical-treated cells in the
high-density cell cultures used in the transformation
assay. Thus, this assay was used not only to select treat-
mentdoses forthetransformation assay, but also toverify
that the test chemical treatments had an acceptable
Table 2. Test chemical transformation responses in experiments with different statistical sensitivities to detect spontaneous
transformation and different detection sensitivities for BaP-induced transformation.
Transformation responsea
Spontaneous,c
Irial no. type III foci/vessel: BaP,e Test chemical,d
Chemical (exp. no.)b rank orderd cal/rank orderd call/mean t-statistic
Active chemicals
Aphidicolin
Barium chloride-2H20
5-Bromo-2'-deoxyuridine
C. I. Direct blue 15
trans-Cinnamaldehyde
Cytosine arabinoside
1 (DR11)
2 (97)
1 (42)
2 (53)
1 (IP3)
2 (IP7)
3 (95)
1 (64)
2 (69)
1 (79)
2 (94)
1 (IP4)
2 (IP7)
3 (95)
1 (75)
2(91)
1 (49)
2 (57)
1 (47)
2 (56)
Diphenylnitrosamine
Manganese sulfate-H20
0.939
0.414
0.861
2.78
0.149
0.992
2.84
0.291
0.288
5.12
1.52
0.278
0.992
2.84
0.882
0.322
0.433
0.278
0.579
0.260
-56 SP ND
54 SP 44
55 SP 8***
11 SP 39
- 102* SP ND
-52 SP ND
8* SP 29
92 SP 71
85 SP 102***
4 SP 1
18 SP 31
'90 SP ND
-52 SP ND
8* SP 29
21 SP 21**
56 LA 109***
65 SP 32
86 SP 74
61 SP 47
84 SP 84*
LA 1.88
SP 7.68
SP 5.67
LA 0.663
SP 20.5
SP 5.43
LA 1.93
SP 5.61
SP 3.64
LA 4.85
SP 2.51
SP 19.3
SP 4.46
SP 5.09
SP 1.83
SN 0.983
SP 4.41
SP 2.19
SP 2.82
SP 2.76
(Continued on nextpage)
Z-Miercaptobenzimidazole
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ITable 2. Continued.
Transformation response'
Spontaneous,c
Trial no. type III foci/vessel: Bap,e Testchemical,"
Chemical (exp. no.)b rank orderd call/rank orderd call/mean t-statistic
Mezerein 1 (59) 0.297 75 SP 76 SP 13.9
2 (95) 2.84 8* SP 29 SP 13.1
Riddelliine 1 (48) 0.537 64 SP 84* SP 4.03
2 (66) 0.056 108** SP 99*** LA 1.84
2,6-Xylidine 1 (84) 0.511 44 SP 65 LA 2.02
2 (100) 0.268 73 SP 49 SP 2.68
Chemicals with equivocal activity
C. I. Direct blue 218 1 (49) 0.433 65 SP 65 LA 1.38
2 (58) 0.189 97 SP 102*** LA 2.58
Mono(2-ethylhexyl)phthalate 1 (79) 5.12 4** SP 1 LA 3.05
2 (94) 1.52 18 SP 31 LA 1.31
Inactive chemicals
Carisoprodol 1 (46) 0.384 88 SP 77 SN 0.000
2 (52) 1.09 34 SP 45 SN 1.53
Chloramphenicol sodium succinate 1 (49) 0.433 65 SP 32 SN 0.000
2 (58) 0.189 97 SP 94** SN 0.580
4-Chloro-2-nitroaniline 1 (46) 0.384 88 SP 77 SN 0.053
2 (53) 2.78 11* SP 39 SN 0.113
C. I. Acid red 114 1 (64) 0.291 92 SP 72 SN 0.868
2 (69) 0.288 85 SP 102*** SN 0.670
Isobutyraldehyde 1 (78) 3.28 9* SP 37 LA 4.01
2 (106) 1.30 28 SP 15*** SN 0.000
Methdilazine-HCl 1 (47) 0.579 61 SP 47 SN 0.000
2 (55) 0.129 104* SP 90*** SN 1.22
Mono(2-ethylhexyl)adipate 1 (82) 8.01 1 SP 3 LA 1.08
2 (94) 1.52 18 SP 31 SN 0.127
Sodium fluoride 1 (70) 0.526 47 SP 43 SN 0.000
2 (101) 0.260 62 SP 48 LA 1.67
12-O-Tetradecanoylphorbol-13-acetate 1 (70) 0.526 47 SP 43 SN 0.000
2 (105) 0.581 29 SP 105* SN 0.000
Chemicals with an indeterminate activity
2,6-Dinitrotoluene 1 (91) 0.322 56 SP 105** LN 0.000
2 (105) 0.581 29 SP 97*** SN 0.000
Abbreviations: exp. no., experiment number; ND, not determined; SP, sufficient positive; LA, limited activity, SN, sufficient negative; LN, limited
negative.
aTheassaydesign andproceduresusedinthe standard transformation assayare described inMaterials and Methods. Thetransformingactivities of
individualchemical treatmentdoses (i.e., focus data), aswell astheindividual transformation responses (i.e., type IIIfoci/vessel), areprovided in detail
in Appendix A.
bMost of the chemicals were tested in 110 sequential experiments using a standard procedure (16,18); however, certain chemicals were tested in
experiments thatcompared the standard protocol to analternative method (e.g., experiments labeled DRI, IP). Onlytheresults ofthestandard method
are presented here.
cThe method used to calculate the spontaneous response, as well as the positive control and test chemical responses, is explained in Materials and
Methods. Thetransformation responses areexpressed astype IIIfoci/vessel andwerecalculated usingalog1omathematicaltransformationprocedure.
The arithmetic value for foci/vessel in this table is the antilog of the log1o mean transformation minus one. The procedure for rank ordering the
spontaneous responses from110experimentsisbased onthedifferentstatistical sensitivities oftransformationexperimentswithdifferentspontaneous
responses is explained in Materials and Methods. Experiments with high spontaneous responses have a high statistical sensitivity and relatively low
rank-order numbers. For example, trans-cinnamaldehyde had a high spontaneous response of 5.12 foci/vessel in experiment 79, which had a high
statistical sensitivity and rank order number of4/110. Conversely, experiments with a low statistical sensitivity have high rank-order numbers. For
example, riddelliine had alowspontaneous response of0.056foci/vessel in experiment 66, which had alowstatistical sensitivitywith ahigh rank-order
number of108/110.
dThemethodused to callindividual experiments is described in detail in Materials and Methods. The significance ofthetransformationresponses of
individual chemical treatment doses were calculated usingSAS software (25). The mean t-statistic represents the average ofthe t-statistics ofthe four
test chemical treatment doses in the experiment. The t-statistics used in these calculations are provided in Appendix A.
eThemethod used to call individual transformation experiments is described in detail in Materials and Methods. Themethod used to rank-orderthe
BaP transformation responses from the 110 experiments is based on statistical comparison of the BaP transformation at the two treatment doses
detected in an individual experimentwith the mean historical activity ofthe assay(18). The rational forrank-ordering the experimentsis analogous to
that described for the spontaneous transformation responses (16).
*Significant spontaneous or BaP transformation response, 0.01 < p < 0.05.
**Significant spontaneous or BaP transformation response, 0.001 < p < 0.01.
***Significant spontaneous or BaP transformation response, p < 0.001.
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cytotoxic effect on the target cells. The standard clonal
survival assay was shown to be inaccurate for both of
these purposes.
The results of co-culture clonal survival assay experi-
ments for 24 chemicals tested in two or more experiments
are summarized Table 1. The chemicals are listed in alpha-
betical orderalongwith a summaryofthephysicochemical
properties thatinfluencedthemethodsbywhichthechem-
icals were handled and tested. The first chemical,
aphidicolin, wascytotoxic to the BALB/c-3T3 cells and had
an average cytotoxic response, or LD50, of 0.000414 mM.
Based on amolecularweightof338.5, this concentration of
aphidicolin was equivalent to 0.146 ,ug/mL. In contrast,
the least cytotoxic chemical was chloramphenicol sodium
succinate, which had an LD50 of5.62 mM and was equiv-
alent to 2315 pg/mL.
Themethods bywhich testchemical technical problems
related to different physicochemical properties were han-
dled in this investigation are discussed in Materials and
Methods. While most of the technical problems, such as
volatility, couldbe adequately overcome through the use of
aconsistentmethodology, twoproblems wereinsurmount-
able in this investigation and could have influenced the
results in these experiments. First, three test chemicals
wereoxidizedwhenexposedtoair(trans-cinnamaldehyde,
isobutyraldehyde, and riddelliine). This problem could be
partially avoided by storing the chemicals under an inert
atmosphere, butitcouldnotbeavoidedin an assaythathas
a 48 hr, 37°C, treatment period in a 95% air atmosphere.
Second, one of the test chemicals, barium chloride, only
exhibited significant cytotoxic activity (< 50% RCE) at
treatmentdoses aboveits solubilitylimitinmedium. Thus,
this chemical was tested at treatment doses both above
and below its solubility limit.
Transforming Activities of24 Test
Chemicals
Thevariable spontaneous and BaP-induced transforma-
tion responses detected in these experiments have been
reported as part of a total of110 experiments (15,16). Due
to the variability among spontaneous transformation
responses, these experiments had different statistical sen-
sitivities to detect chemical-induced transformation
responses. Likewise, variability among BaP responses
showed that individual experiments had different detec-
tion sensitivities for BaP and could have had different
sensitivities to measure test chemical-induced transfor-
mation responses. Therefore, test chemical transforma-
tion responses were evaluated in terms of the rank-
ordered sensitivity of individual experiments in terms of
their spontaneous and BaP-induced transformation
responses.
In this investigation, 24 chemicals were tested in two or
moreexperimentsin amodified standard BALB/c-3T3 cell
transformation assay. The results of these experiments
aresummarizedinTables2 &3, andtheexperimental data
are provided in detail in Appendix A. Explanations ofthe
different acceptance and evaluation criteria for the trans-
formation assay response calls is provided in Materials
and Methods. The activities ofthe individual chemicals is
describedbelow, andtheactual and estimatedrankorders
of the individual test chemical transformation responses
are provided in Table 3.
Aphidicolin. Aphidicolin was a very cytotoxic chemical
with an average LD50 of0.000414 mM and noinsurmount-
able technical problems (Iable 1). The statistical sensitiv-
Table 3. Actual and estimated rank-ordered potency of
the responses of24 chemicals detected in a standard
transformation assay.
Transformation response,
rank t-statistica
Chemical Actual Estimated
Active chemicals
Mezerein 13.6 13.6
Cytosine arabinoside 8.35 8.35
5-Bromo-2'-deoxyuridine 7.35 7.35
C. I. Direct blue 15 4.62 7.35
Aphidicolin 5.13 5.38
Riddelliine 2.94 4.73
Manganese sulfate-H20 3.66 4.28
trans-Cinnamaldehyde 3.85 3.85
2-Mercaptobenzimidazole 2.79 3.49
Barium chloride-2H20 3.17 3.17
2,6-Xylidine 2.35 2.47
Diphenylnitrosamine 1.40 1.40
Chemicals with equivocal activity
C. I. Direct blue 218 2.07 3.11
Mono(2-ethylhexyl)phthalate 2.08 2.08
Inactive chemicals
C. I. Acid red 114 0.77 1.23
Isobutyraldehyde 1.05 1.05
Carisoprodol 0.92 0.98
Sodium fluoride 0.84 0.84
Methdilazine-HCI 0.61 0.84
Mono(2-ethylhexyl)adipate 0.61 0.61
Chloramphenicol sodium succinate 0.29 0.38
4-Chloro-2-nitroaniline 0.08 0.08
12-O-Tetradecanoylphorbol-13- 0.00 0.00
acetate
Chemical with indeterminate activity
2,6-Dinitrotoluene 0.00 0.00
aThe method used to calculate the significance oftest chemical trans-
formation responses used SAS software (24) and is described in detail in
MaterialsandMethods. Thecorrectt-statistics ofeach treatmentdoseof
thetestchemicalin asingleexperiment arepresented intheAppendixA,
and these t-statistics were averaged to determine the mean t-statistic of
thetestchemicalfortheexperiment (seeTable2).Themeant-statisticfor
two or experiments for each chemical were weighted according to the
number of treatment doses evaluated and averaged to determine the
actual rank t-statistic presented in this table. For example, the actual
rank t-statistic ofmezerein transformation responses in experiments 59
and 95is equal to 13.6 [4.01 + 9.05 + 17.0 + 25.7 (experiment59) + 5.63
+ 20.3 + 13.5 (experiment 95)/7 = 13.6].
bThe estimated rank t-statistic is used to estimate both the historical
activity of the test chemical in the transformation assay, as well as to
predict its activity in additional tests. It is calculated by correcting the
actual rank t-statistic using a correction factor. The data presented in
Iable 2 show that individual experiments had different rank-ordered
sensitivities to detect chemical-induced transformation. Therefore, the
estimated rank t-statistic modified the actual rank t-statistic to correct
for differences in the sensitivities ofindividual experiments. The method
uses the rank-ordered sensitivity of individual experiments to detect
spontaneous and BaP-induced transformation (see Materials and
Methods for an example).
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ities oftrials 1 and 2 were 56 and 54/110, respectively; the
detection sensitivities for BaP of trials 1 and 2 were not
determined (ND) and 44/110, respectively (Table 2). In a
preliminary trial 1, the test chemical was tested at widely
spaced treatment doses, and it had an LAtransformation
response. In trial 2, the chemical had an SP transforma-
tion response. Aphidicolin was evaluated as very active in
the transformation assay, and its actual and estimated
rank t-statistics were 5.13 and 5.38, respectively (Table 3).
Barium chloride-2H20. Barium chloride-2H20 was a
moderately cytotoxic chemical with an average LD50 of
1.70 mM and one technical problem (Table 1). It had a
solubilitylimitofabout400 ,ug/mL inmedium; thus,itwas
tested for cytotoxic and transforming activities at treat-
mentdosesbothbelowand above this limit. The statistical
sensitivities of trials 1 and 2 were 55 and 11/110, respec-
tively; the detection sensitivities for BaP oftrials 1 and 2
were 8 and 39/110, respectively (Table 2). In a preliminary
trial 1, the chemical was tested at two doses above the
solubilitylimitandhad anSPtransformation response. In
trial 2, the chemical was tested with only one dose above
the solubility limit, and it had an LA transformation
response. Barium chloride-2H20 was evaluated as active
in the transformation assay, but only at doses above its
solubilitylimitinculturemedium. Itsactual andestimated
rank t-statistics were both 3.17 (Table 3).
5-Bromo-2'-deoxyuridine. 5-Bromo-2'-deoxyuridine
was a very cytotoxic, light-sensitive chemical with an
averageLD50of0.0612mMandnoinsurmountabletechni-
calproblems (Tlable 1). The statistical sensitivities oftrials
1-3 were 102, 52, and 8/110, respectively; the detection
sensitivitiesforBaPoftrials1-3wereND,ND,and29/110,
respectively (Table 2). In a preliminary trials 1 and 2, the
chemical had an SP transformation response. In trial 3,
the chemical had an unexpectedly low LAtransformation
response. 5-Bromo-2-deoxyuridine was evaluated as very
active in the transformation assay, and its actual and
estimated rank t-statistics were both 7.35 (Table 3).
Carisoprodol. Carisoprodol was amoderately cytotoxic
chemical with an average LD50 of3.33 mM with no insur-
mountable technical problems (Table 1). The statistical
sensitivities oftrials 1 and 2 were 88 and 34/110, respec-
tively; the detection sensitivities for BaP oftrials 1 and 2
were 77and45/110, respectively(Table2). Intrials 1 and2,
the chemical had SN transformation responses. Car-
isoprodol was evaluated as inactive in the transformation
assay, and its actual and estimated rank t-statistics were
0.92 and 0.98, respectively (Table 3).
Chloramphenicol Sodium Succinate. Chlorampheni-
col sodium succinate was a moderately cytotoxic chemical
with an average LD50 of5.62 mM and no insurmountable
technicalproblems (Table 1).Thestatistical sensitivities of
trials 1 and 2 were 65 and 97/110, respectively; the detec-
tion sensitivities for BaP of trials 1 and 2 were 32 and
94/110, respectively (Table 2). In trial 1, the chemical had
anSNtransformationresponse, andintrial2,whichhad a
relativelylowsensitivity to detectchemical-induced trans-
formation, the chemical also had an SN transformation
response. Chloramphenicol sodium succinate was evalu-
ated asinactive inthe transformation assay, and its actual
and estimated rank t-statisticswere 0.29 and 0.38, respec-
tively (Table 3).
4-Chloro-2-Nitroaniline. 4-Chloro-2-nitroanilinewas a
cytotoxic chemicalwith an average LD50 of0.638mM and
noinsurmountabletechnicalproblems(Table1).Thestatis-
tical sensitivities of trials 1 and 2 were 88 and 11/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2were 77 and 39/110, respectively (Table 2). In trials 1
and 2 the chemical had SN transformation responses.
4-Chloro-2-nitroaniline was evaluated as inactive in the
transformation assay, and its actual and estimated rank
t-statistics were both 0.08 (Table 3).
C. I. Acid Red 114. C. I. Acid red 114 was a cytotoxic
chemical with an average LD50 of 0.719 mM and no
insurmountable technical problems (Table 1). The statisti-
cal sensitivities of trials 1 and 2 were 92 and 85/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 72 and 102/110, respectively (Table 2). Thus,
trials 1 and 2 had relatively low sensitivities to detect
chemical-induced transformation. In trials 1 and 2, the
chemical had SN transformation responses; therefore,
C.I. acid red 114 was evaluated as inactive in the transfor-
mation assay. The chemical's actual rank t-statistic was
0.77, and due to the low sensitivities of the two experi-
ments, the estimated rank t-statistic was 1.23 (Table 3).
Thus, C.I. acid red 114 had the highest probability ofthe
nine inactive chemicals of exhibiting activity in a third
experiment.
C. l. Direct Blue 15. C.I. Direct blue 15 was a light-
sensitive, relativelynoncytotoxic chemicalwith an average
LD50 of 2.68 mM and no insurmountable technical prob-
lems (Table 1). The statistical sensitivities oftrials 1 and 2
were92and85/110,respectively; thedetectionsensitivities
for BaP oftrials 1 and 2 were 71 and 102/110, respectively
(Table 2). Thus, trials 1 and 2 had a relatively low sen-
sitivities to detect chemical-induced transformation. In
trials 1 and 2 the chemical had SP transformation
responses; therefore, C.I. direct blue 15 was evaluated as
very active in the transformation assay. The chemical's
actual rank t-statistic was 4.62, but the estimated rank
t-statistic was 7.35 due to the relativelylow sensitivities of
the experiments (Table 3).
C. I. Direct Blue 218. C. I. Direct blue 218 was a
cytotoxic chemicalwith an average LD50 of0.448 mM and
noinsurmountabletechnicalproblems(Table 1).Thestatis-
tical sensitivities of trials 1 and 2 were 65 and 97/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2were 65and102/110, respectively (Table2). Intrial 1,
the chemical had an LAtransformation response. In trial
2,which had arelativelylowsensitivityto detectchemical-
induced transformation, the chemical also had an LA
transformation response. Thus, C.I. direct blue 218 was
evaluated as having equivocal activity in the transforma-
tion assay. The chemical's actual rank t-statistic was 2.07;
however, the estimated rank t-statistic was 3.11 (Table 3).
Thus,thelowsensitivityofthesecondtrialmakesithighly
probable that this test chemical could exhibit activity in a
third experiment.
Trans-Cinnamaldehyde. Thans-cinnamaldehyde was a
very cytotoxic chemical with an average LD50 of 0.0535
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mM and many physicochemical properties that required
special attention (Table 1). Although most ofthese techni-
calproblems couldbeovercome,thechemicalwasreported
tobeoxidizedinair. Duetothelongtreatmentperiodof48
hr at 37°C in a 95% air atmosphere, it is likely that the
chemical tested in this investigation included both the
parentchemical and some ofits oxidativeby-products. The
statistical sensitivities oftrials 1 and 2 were 4 and 18/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 1 and 31/110, respectively (Table 2). In a
preliminary trial 1 which had a relatively high sensitivity
to detect chemical-induced transformation, the chemical
had an LAtransformation response. In trial 2,which also
hadarelativelyhigh sensitivitytodetectchemical-induced
transformation, the chemical had an SP transformation
response. Therefore, trans-cinnamaldehyde was evalu-
ated as active in the transformation assay. Its actual and
estimated rank t-statistics were 3.85 (Table 3).
CytosineArabinoside. Cytosinearabinosidewasavery
cytotoxic chemical with an average LD50 of0.000601 mM
and no insurmountable technical problems (Table 1). The
statistical sensitivities oftrials 1, 2, and 3 were 90, 52, and
8/110, respectively; the detection sensitivities for BaP of
trials 1 and2wereND,ND, and29/110,respectively(Table
2). In trials 1-3 the chemical had an SP transformation
response. Therefore, cytosine arabinoside was evaluated
as very active in the transformation assay, and its actual
and estimated rank t-statistics were both 8.35 (Table 3).
2,6-Dinitrotoluene. 2,6-Dinitrotoluene was a moder-
atelycytotoxic chemicalwith an average LD50 of2.03 mM
and no insurmountable technical problems (Table 1). The
statistical sensitivities oftrials 1 and2were 56and29/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 105 & 97/110, respectively (Table 2). In a
preliminarytrial1,whichhadarelativelylowsensitivityto
detect chemical-induced transformation, the chemical did
notinduce significant cytotoxic activity andwas evaluated
as having an unacceptable LN transformation response.
Trial2alsohadarelativelylowsensitivity,butthechemical
treatments had significant cytotoxic activity. Trial 2 was
evaluated as an SN transformation response. Therefore,
2,6-dinitrotoluene was evaluated as having an indetermi-
nate activity in the transformation assay, and it has to be
tested in a third experiment before its activity in the
BALB/c-3T3 cell transformation can be clearly defined.
The actual and estimated rank t-statistics were both 0.00
(Table 3).
Diphenylnitrosamine. Diphenylnitrosamine was a
cytotoxic chemical with an average LD50 of0.479 mM and
noinsurmountabletechnicalproblems(Table 1).Thestatis-
tical sensitivities of trials 1 and 2 were 21 and 56/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 21 and 109/110, respectively (Table 2). In a
preliminary trial 1, which had a relatively high sensitivity
to detect chemical-induced transformation, the chemical
had an SP transformation response. In contrast, trial 2
had a low sensitivity to detect chemical-induced transfor-
mation, and the chemical had an SN transformation
response.Although this chemical had disparate responses
in two transformation experiments, there was no signifi-
cant difference in the mean t-statistic of the two experi-
ments. Furthermore, the chemical exhibited increased
transformation responses in the same range of doses in
trial 2 that were statistically significant in trial 1. There-
fore, diphenylnitrosamine was evaluated as weakly active
in the transformation assay, and its actual and estimated
rank t-statistics were both 1.40 (Table 3). Therefore, this
chemicalwastheleastactiveofthe12activechemicals, and
it had the lowest probability ofthe 12 active chemicals of
being active in athird experiment.
Isobutyraldehyde. Isobutyraldehyde was amoderately
cytotoxic chemical with an average LD50 of4.37 mM and
several technicalproblems (Table 1).Although most ofthe
technical problems could be overcome, the chemical was
reported to be oxidized in air. Due to the long treatment
period of48hr at37°C in a95% airatmosphere, itis likely
thatthechemicaltestedinthisinvestigationincludedboth
the parent chemical and some ofits oxidative by-products.
The statistical sensitivities of trials 1 and 2 were 9 and
28/110, respectively; the detection sensitivities for BaP of
trials 1 and 2were 37 and 15/110, respectively (Table2). In
trials 1 and 2, which had a relatively high sensitivities to
detectchemical-induced transformation, the chemicalhad
an LA and SN transformation responses. Therefore,
isobutyraldehyde was evaluated as inactive in the trans-
formationassay,anditsactualandestimatedrankt-statis-
tics were both 1.05 (Table 3).
ManganeseSulfate-H20. Manganese sulfate-H20 was
a very cytotoxic chemical with an average LD50 of 0.100
mM and no insurmountable technical problems (Table 1).
The statistical sensitivities of trials 1 and 2 were 65 and
86/110, respectively; the detection sensitivities for BaP of
trials 1 and 2 were 32 and 74/110, respectively (Table 2).'
The chemical had SP transformation responses in both
trials 1 and 2. Therefore, manganese sulfate-2H20 evalu-
ated as very active in the transformation assay, and its
actual and estimated rank t-statistics were 3.66 and 4.28,
respectively.
2-Mercaptobenzimidazole. 2-Mercaptobenzimidazole
was amoderatelycytotoxicchemicalwith anaverageLD50
of 3.25 mM and no insurmountable technical problems
(Table 1). The statistical sensitivities oftrials 1 and 2were
61 and 84/110, respectively; the detection sensitivities for
BaP of trials 1 and 2 were 47 and 84/110, respectively
(Table 2). In a preliminary trial 1, the chemical had an SP
transformation response. In trial 2,which had arelatively
lowsensitivityto detect chemical induced transformation,
the chemical also had an SP transformation response.
Therefore, 2-mercaptobenzimidazole was evaluated as
veryactive inthe transformation assay, and its actual and
estimatedrankt-statisticswere2.79and3.49,respectively
(Table 3).
Methdilazine-HCI. Methdilazine-HCl was a very
cytotoxicchemicalwithanaverageLD50of0.0314mMand
noinsurmountabletechnicalproblems(Table1).Thestatis-
tical sensitivities of trials 1 and 2 were 61 and 104/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 47 and 90/110, respectively (Table 2). In a
preliminary trial 1, the chemical had an SN transforma-
tion response. In trial 2, which had a low sensitivity to
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detect chemical-induced transformation, the chemical had
an SN transformation response. Therefore, methdilazine
was evaluated asinactive inthetransformation assay, and
its actual and estimated rank t-statistics were 0.61 and
0.84, respectively (Table 3).
Mezerein. Mezerein was averycytotoxic chemicalwith
an average LD50 of 0.0306 mM and no insurmountable
technicalproblems (Table 1).Thestatistical sensitivities of
trials 1 and2were 75and8/110,respectively; thedetection
sensitivities for BaP oftrials 1 and 2 were 76 and 29/110,
respectively (Table2). Intrials 1 and2thechemicalhad an
SP transformation response. Therefore, mezerein was
evaluated as very active in the transformation assay. The
actual and estimated rank t-statistics were both 13.6
(Table3);thus,mezereinisoneofthemostactivechemicals
in the BALB/c-3T3 cell transformation assay.
Mono(2-ethylhexyl)adipate. Mono(2-ethylhexyl)-
adipate was amoderately cytotoxic chemicalwith an aver-
age LD50 of 1.12 mM and no insurmountable technical
problems (Table 1). The statistical sensitivities oftrials 1
and 2 were 1 and 18/110, respectively; the detection sen-
sitivities for BaP of trials 1 and 2 were 3 and 31/110,
respectively (Table 2). In apreliminarytrial 1,which had a
very high sensitivity to detect chemical-induced transfor-
mation, the chemical had an LAtransformation response.
In trial 2, which had a relatively high sensitivity to detect
chemical-induced transformation, the chemical had an SN
transformation response. Therefore, mono(2-ethylhexyl)-
adipate was evaluated as inactive in the transformation
assay, and the actual and the estimated rank t-statistics
were both 0.61 (Table 3).'
Mono(2-ethylhexyl)phthalate. Mono(2-ethylhexyl)-
phthalate was a,moderately cytotoxic chemical with an
-average.LD50of1.04mMand noinsurmountable technical
problems (Table 1). The statistical sensitivities of trials 1
and 2 were 4 and 18/110, respectively; the detection sen-
sitivities for BaP of trials 1 and 2 were 1 and 31/110,
respectively (Table2). In apreliminarytrial 1,which had a
very high sensitivity to detect chemical-induced transfor-
mation, the chemical had an LAtransformation response.
In trial 2, which also had a relatively high sensitivity to
detect chemical-induced transformation responses, the
chemical also had an LAtransformation response. There-
fore, mono(2-ethylhexyl)phthalate was evaluated as hav-
ing equivocal activity in the transformation assay, and its
actual and estimated rank t-statistics were both 2.08.
Thus, ofthe two test chemicals with equivocal activity in
this investigation, this chemical had alowerprobability of
being active in athird transformation experiment than C.
I. direct blue 218 (Table 3).
Riddelliine. Riddelliine was a moderately cytotoxic
chemical with an average LD50 of 4.78 mM and several
technicalproblems (Table 1).Although mostoftheseprob-
lemscouldbesurmounted,thechemicalwasreportedtobe
oxidized by air. Because the chemical is exposed to a long
treatmentperiod of48hrat37°C in a95% airatmosphere,
itishighlylikelythatthechemicaltestedinthisinvestiga-
tionincludedboththeparentchemicalitsandoxidativeby-
products. Thestatistical sensitivities oftrials 1 and2were
64 and108/110, respectively. The detection sensitivities for
BaP of trials 1 and 2 were 84 and 99/110, respectively
(Table 2). In a preliminary trial 1, the chemical had an SP
transformation response. In trial 2, which had a very low
sensitivityto detectchemical-induced transformation, the
chemical had an LA transformation response. Therefore,
riddelliine was evaluated as active in the transformation
assay. Due to the relatively low sensitivity of the second
trial, the estimated rank t-statistic was 4.73 and much
higher than the actual rank t-statistic of2.94 (Table 3).
Sodium Fluoride. Sodium fluoride was a moderately
cytotoxic chemical with an average LD50 of2.31 mM and
noinsurmountabletechnicalproblems(Table1).Thestatis-
tical sensitivities of trials 1 and 2 were 47 and 62/110,
respectively; the detection sensitivities for BaP oftrials 1
and 2 were 43 and 48/110, respectively (Table 2). In a
preliminary trial 1, the chemical had an SN transforma-
tion response, and in trial 2 the chemical had an LA
response. Therefore, sodium fluoride was evaluated as
inactive in the transformation assay, and its actual and
estimated rank t-statistics were both 0.84 (Table 3).
12-O-Tetradecanoyl-Phorbol-13-Acetate. 12-O-Tetra-
decanoyl-phorbol-13-acetate (TPA) was a very cytotoxic
chemical with an average LD50 of 0.0145 mM and no
insurmountable technical problems (Table 1). The statisti-
cal sensitivities of trials 1 and 2 were 47 and 29/110,
respectively; the detection sensitivities for BaP oftrials 1
and2were43and105/110,respectively(Table2). Intrials 1
and 2, the chemical had SN transformation responses.
Therefore, TPAwas evaluated as inactive in the transfor-
mationassay;,anditsactualandestimatedrankt-statistics
were both 0.00 (Table 3).
2,6-Xylidine. 2,6-Xylidine was a moderately cytotoxic
chemical with an average LD50 of4.86 mM and no insur-
mountable technical problems (Table 1). The statistical
sensitivities of trials 1 and 2 were 44 and 73/110, respec-
tively; the detection sensitivities for BaP oftrials 1 and 2
were65and49/110,respectively(Table2). Inapreliminary
trial 1, the chemical had an LA transformation response.
In trial 2, the chemical had an SP transformation
response. Therefore, 2,6-xylidine was evaluated as active
in the transformation assay, and its actual and estimated
rank t-statistics were 2.35 and 2.47, respectively (Table3).
Discussion
This investigation reports the results of using a new
sensitive method to detect cytotoxic (17) and transforma-
tion responses (10,11) of 24 test chemicals using a clone
A31-1-13 ofBALB/-3T3 cells (13-15). The newmethod has
enhanced sensitivity for detecting chemical-induced
transformation compared to published procedures
(2,4,5,27-29), andtheenhanced sensitivityofthe transfor-
mation assay procedure is due to three procedural
changes from published procedures. First, the published
method ofdetecting chemical-induced cytotoxic effects on
cells in culture uses a standard clonal survival assay(1-3)
employing 200 WT cells, and this method inaccurately
measures the cytotoxic responses of chemicals in high-
density cell cultures (17). For most chemicals, the clonal
survival assayusing200WTcellsoverestimatesthechem-
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ical's cytotoxicactivitywhenitisappliedtotransformation
assays (17), as well as assays for detecting cell to cell
communication activitiesin cultured mammalian cells (30).
This investigation used a co-culture clonal survival assay
that quantitatively and accurately measured the RCE of
chemical-treated cels at the same cell densities used to
measure the induction of the transformed cell phenotype
(14). The LD50cytotoxic responses ofthe 24testchemicals
are presented in Table 1.
Second, the standard BALB/c-3T3 and C3H1OT1/2
transformation assaymethods havebeenreported to have
a low sensitivity for detecting chemical-induced transfor-
mation (4,27). Although many investigators have assumed
this problem relates to deficiencies in host cell metabolism
(4), this report introduces an assay method with high
sensitivity to detect the chemical-induced transformation
of BALB/c-3T3 cells in the absence of any exogenous
activation system(11).Theenhanced sensitivityofthis new
method arose in part through the use of an increased
seeding density of the target cells from 1 x 104 to
3.2 x 104 and a delay in the treatment ofthe cell cultures
on day 1 to day 2 (see Materials and Methods). This
increased the total number of treated cells from approx-
imately 0.3 x 106to 2.0 x 106 eells in atreatment setof20
culturevessels.
Third, traditional methods of solubilization of test
chemicals for in vitro genotoxicity assays have relied on
the use of a single organic solvent. This procedure rarely
offers any improvement in the inherent solubility of the
test chemical in culture medium, because the chemical
solubilizedinthepreferredorganic solventusuallyprecipi-
tated when dispersed into the polar culture medium
environment. This technical problem was overcome for
many test chemicals in this investigation by using a two-
step solubilization procedure. The test chemical was first
dissolved in an appropriate organic solvent, and then the
test chemical in the organic solvent was further diluted
with medium supplemented with a noncytotoxic, nonionic
surfactant, pluronic F68 (21). The presence ofthe pluronic
F68 expanded the relative solubility range ofmanychemi-
cals, as well as forming a stable emulsion or fine-
particulate suspension for other chemicals (11).
Thisinvestigation hasalso studiedtheproblemofestab-
lishing criteria for the evaluation activity of chemical-
induced transformation responses in a single experiment.
Previous reports have considered a chemical-induced
transformation response from a single experiment to be
adequate for evaluating a chemical in the BALB/c-3T3
transformation assay (1-2,4). Furthermore, some investi-
gators have argued that a single chemical treatment dose
with statistically significant activity was sufficient evi-
dencefor apositive responsein atransformation assay(4-
5,28,29). Our investigation has led to what we believe are
more adequate methods for analysis of chemical-induced
transformation response data obtained in the BALB/
c-3T3 cell transformation assay. New assay evaluation
criteria were developed for a chemical tested in a single
trial (See Materials and Methods), as well as a method to
analyze data obtained from replicate trials for one chemi-
cal (Tables 2 and 3).
The transformation assay evaluation criteria for a sin-
gle transformation assay trial are explained in Materials
and Methods. These four criteria were modeled after the
rodent bioassay evaluation criteria used U. S. Environ-
mental Protection Agency (EPA) Gene-Tox Program
Report (8), and consist of sufficient positive, limited
activity, sufficient negative, and limited negative
responses. These four responses can be used to evaluate
either the type III focus transformation response or
transformation responses that include type I and II foci.
The majority of test chemicals that induced SP transfor-
mation responses in this investigation had their highest
activitydetected attreatmentdoses thatweremoderately
cytotoxic to the cells (11); therefore, it was necessary to
examinealltestchemicals attreatmentdosesthatresulted
in significant cytotoxic responses (i.e., at the LD50 dose
level detected in the co-culture clonal survival assay). The
difference between the SP and LA transformation
responsesrelated totheappearanceofstatisticallysignifi-
cant transformation responses at consecutive treatment
doses. The SP response had a statistically significant
response at two or more consecutive treatment doses,
whereas the LA response had only one dose with signifi-
cant(p<0.01)activity. Iftestchemicaltreatmentswerenot
cytotoxic and significant transformants were not
observed, thenthe experimentwasunacceptable and eval-
uated as having an LN response. The SN response was
assigned to inactive test chemicals that had a significant
cytotoxic response.
Nevertheless, the most important criterion for deter-
mining the presence or absence of activity in a BALB/
c-3T3celltransformation assayis nottheresultofasingle
transformation assaytrial, butratherthe results obtained
in two or more independent experiments (11). Although
some chemicals induced transformation responses at two
or more treatment doses that were 10-fold above the
spontaneous transformation response, most active chemi-
calshadlessobviousresponses. Therefore, relativelysmall
increases in the frequency of chemical-induced transfor-
mants had to be determined statistically, and the repeat-
ability of chemical responses in two experiments was
considered as the most convincing evidence for activity in
the BALB/c-3T3 transformation assay.
Intheprocess ofconsideringthe traditionalmethods of
analysis ofchemical-induced transformation ofBALB/-3T3
(1-5) andC3H1OT1/2 (19) cells, aswell as genotoxic effects
of chemicals in other in vitro systems, a critical flaw was
observed when data were combined from multiple trials.
These methods assumed thatindependent trials had iden-
tical sensitivities to measure phenotypic changes. How-
ever, a historical analysis of the BALB/c-3T3 cell
transformation assayrevealed that the frequencyofspon-
taneous and positive control observations were highly
variable (15,18). Furthermore, when the phenotypic fre-
quency of the spontaneous control varied, it affected the
inherent statistical sensitivity of the experiment (16).
Experiments with high spontaneous responses had rela-
tively high sensitivities to resolve significant (or fold)
increases in activity. In contrast, experiments with low
spontaneous responses had relatively low sensitivities to
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resolve significant activities. Similarly, variability among
positive control responses demonstrated that the target
cells had inherently different sensitivities to detect
chemical-induced transformation indifferentexperiments.
If one ignored this variability among the positive and
negative controls, oneimposed abias ontheinterpretation
of the test chemical responses in the same experiments.
For example, when test chemical responses in two trials
were disparate, the differences were automatically associ-
ated with the behavior of the test chemical and not to
potentialdifferencesinthesensitivitiesoftheexperiments
to detect the phenotypic change in the WT cells.
The above-mentioned problems were overcome in this
investigation through the use of statistical ranking pro-
cedures for chemical-induced transformation responses.
Three newmethods were introduced tofacilitate the anal-
ysis ofchemical-induced transformation responses in the
BALB/c-3T3 cell transformation assay. First, the potency
ofthe chemical transformation responses was determined
by calculating the mean t-statistics (Table 2X The greater
thecombined significanceofthefourt-statisticsofthefour
chemical transformation responses/experiment, the
greater the mean t-statistic. Second, the rank-ordered
potency ofthe test chemical response was determined by
calculating the actual rank t-statistic (Table 3). The actual
rank t-statistic was the average t-statistic for all of the
acceptable experiments for the test chemical. The greater
the average rank t-statistic, the higher the potency ofthe
test chemical transformation response. Third, the esti-
mated rank t-statistic was used to predict the future
response ofthetestchemicalintheassay(Table3). Itused
rank-ordered historical spontaneous and BaP-induced
transformation responses of110experiments to determine
the statistical sensitivities and detection sensitivities for
BaP in each experiment. This information permitted the
correction of the actual rank t-statistic for experiments
with low statistical sensitivity (see Materials and
Methods).
The t-statistic was selected for this purpose for two
reasons. First,theabsolutevalueofthet-statisticvariedin
proportion to the significance ofobservations. For exam-
ple, significant observations with confidence levels of
p<0.001, <0.01 and <0.05 have t-statistics at or above
approximately3.65, about2.70, and1.96. Furthermore, the
significance ofthe observation is notbiasedbyhigh orlow
spontaneous transformation responses in the individual
experiments when the underlying requirements for use of
thet-distribution aremet.Second,theabsolutevalueofthe
t-statistic took into account the variability or variance of
observations in different experiments and different treat-
ment sets within a single experiment.
Rank-ordered transformation datasetswithrankt-sta-
tistics may be used to solve three problems that are not
easily resolved when data are merely classified into two
groups of active and inactive chemicals. First, the mean
t-statistics for a chemical's response in two independent
experiments provide an unbiased means of predicting
whether athird experimental trialfor anytestchemical is
warranted. For example, the two experimental trials for
diphenylnitrosamine had SP and SN transformation
responses. Although these results were disparate, the
explanation forthedifferencein activities was apparentin
the different sensitivities ofthe two experiments and the
overall weak activity of the test chemical. If the mean
t-statisties ofthe twoexperiments are compared, there is
nosignificantdifferenceinthetwoexperiments (Appendix
A). In contrast, there have been several test chemicals in
whichtheactivitiesdetectedintwoindividualexperiments
were SP and SN and the mean t-statisties were signifi-
cantly differentfrom one another. Although therewere no
examples ofthis problem in this investigation, this result
occurred with othertest chemicals, and it demanded that
the test chemical be examined in a third trial. The results
ofthe third trial were pooled with the results ofthe other
two trials to calculate the rank t-statistic.
Thus, the transformation assay response calls of SP,
LA, SN, and LN should only be used to evaluate the
activity from a single experiment. The data from two
experiments should be evaluatedbyexaminingthe relative
significance of activities in replicate trials. If these
activities in two experiments are comparable, then test
chemicals can be judged as having been highly active,
active, equivocal activity, and inactive in the assay. Ifthe
results ofthe two experiments are disparate, then a third
trial may be required to determine which ofthe first two
experiments represents the activity of the test chemical.
Second, the use ofmean t-statistics permits an assess-
ment ofthe relative reproducibility ofthese observations
with different types ofchemicals. For example, one could
compare the reproducibility of mean t-statistics of test
chemicals with different solubilities in culture medium,
different volatilities, and different inherent cytotoxic
activities to the target cells. Third, rank-ordered
responses for active chemicals detected in two experimen-
tal trials permits one to predict the relative probability of
each chemical being active in a third trial. Although the
third trial is not required to determine the activity ofthe
chemical in the assay, it could be conducted in a different
laboratory to determine the reproducibility ofthe results
obtained in the current investigation. An active chemical
with a high estimated rankt-statistic, like mezerein (rank
t-statistic = 13.7), would have a high probability to have
repeatable positive response in the assay (Table 3). Con-
versely, a chemical with a low estimated rank t-statistic,
like diphenylnitrosamine (rank statistic = 1.40), would
have a far lowerprobability ofbeing active in a third trial
and could even be inactive in that experiment. Likewise,
test chemicals with equivocal responses, such as C. I.
direct blue 218 and mono(2-ethylhexyl)phthalate, had dif-
ferentprobabilities ofbeing active in the third trial (Table
3). Finally, the rank t-statistics permitted the ranking of
chemicals thatwere inactive in the assayin terms oftheir
probabilityofbeingdetectedinathirdexperiment.Among
the nine inactive chemicals in this study, C.I. acid red 114
had an estimated rank t-statistic of 1.23, and it had the
highestprobabilityofbeingdetectedin athird trial (Table
3).
Themechanismbywhich 12 differentchemicalsinduced
significant transformation of BALB/c-3T3 cells is best
understood by comparing these data with the data pres-
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ented inreports on detection ofspontaneous (16) and BaP-
induced transformation (18) under identical experimental
conditions. The data presented in both ofthese investiga-
tions suggested, but did not prove, that spontaneous and
BaP-induced transformation were the result ofmutagenic
change in the WT cells. According to this theory, the WT
cellsweregeneticallyaltered, andapermanentphenotypic
change occurred thatallowedthemutated ortransformed
cell to grow within a contact-inhibited monolayer ofcells.
Nevertheless, the genetic lesion and the gene product are
not identified. The hypothesis was based totally on the-
oretical considerations of data obtained in many experi-
ments that were conducted under several different
experimental conditions.
In conclusion, this report presents mathematical
methods using t-statistics that may be used to interpret
and analyze the biological effects and activities ofchemi-
cals in assays usingcultured mammalian cells. The report
also summarized the cytotoxic and transformation
responses of 24 test chemicals in a new experimental
protocol fortheBALB/c-3T3 celltransformation assay. In
two or more independent experiments, 12 chemicals were
active, 2 chemicals had equivocal evidence of activity, 9
chemicals were inactive, and 1 chemical had anindetermi-
nate activity in the assay (Table 3). Using t-statistics, the
relative potency of chemical transformation responses in
groups of chemicals with different activities was deter-
mined. Although the data in this report are limited to a
relatively small group of24 chemicals, the same methods
have been used to interpret the cytotoxicity and transfor-
mation responses >200testchemicals (11,12).
The opinions expressed in this paper are solelythose ofthe authorand
do not necessarily reflect the positions of the U.S. Food and Drug
Administration.
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Appendix A.
Table Al. Summary ofthe transformation responses of24 test chemicals
Cytotoxic
Treatment Activityb Transforming Transformation
Conditiona RCE (%) Activityc Responsed
Focus Data Foci/Vessel
Type Vessels Focus Type Significancee
Drug Conc. mM S.A. CC.A. III (N) III t-statistic
Aphidicol in [APH, M.W. =338.5]
Trial
B(a)P
B(a)P
1 [Exp. DRI1]
.000791
.000250
MNNG .0203
MNNG .0102
MNNG .00508
ND
ND
1.93
3.33
10.6
21.6
96.9
91.5
151 (15)
73 (15)
58 (15)
8.83***
4.48***
2.42**
+ 9.63
+ 6.56
+ 3.33
APH .000295
APH .0000934
APH .0000295
NC Control
Trial
B(a)P
B(a)P
APH
APH
APH
APH
NC
2 [Exp. #97]
.000791
.000250
Control
12.0
70.0
83.0
100.
73.0
103.
89.6
100.
4.74 78.0
17.4 104.
8.70
3.16
29.2
53.8
100.
73 (15)
16 (15)
15 (15)
20 (30)
4.12***
.803
.755
.939
118 (20)
52 (20)
7.94
47.1
93.1
98.8
100.
61 (19)
94 (20)
50 (20)
26 (20)
47 (80)
5.02***
2.26***
2.78***
4.42***
2.13***
1.08**
.414
+ 5.64
0.00 (-0.42)
0.00 (-0.59)
Control
Mean t = 1.88
+ 12.5
+ 7.26
+ 8.25
+ 12.3
+ 6.83
+ 3.32
Control
Mean t = 7.68
Barium Chloride [BACL, M.W. 244.]
Trial 1 [Exp. #42]
B(a)P .000791
B(a)P .000250
2.41 35.7
5.72 65.4
280 (20)
161 (19)
13.7***
7.44***
+ 20.2
+ 9.55
BACL
BACL
BACL
BACL
NC-1
1.84
1.39
.922
.461
Control
Trial 2 [Exp. #53]
B(a)P .000791
B(a)P .000250
1.51
25.3
80.1
98.8
100.
4.73
51.3
88.0
88.0
100.
4.78 58.9
7.97 76.8
142 (19)
93 (20)
51 (20)
22 (19)
52 (40)
182 (20)
195 (20)
7.04***
4.18***
2.06**
.965
.861
8.30***
8.74***
4.10**
1.82
2.63
2.62
2.78
BACL 1.50 10.4 63.7 88 (20)
BACL 1.00 69.3 73.5 33 (16)
BACL .500 101. 83.9 56 (20)
BACL .250 101. 98.7 52 (18)
NC-1 Control 100. 100. 128 (40)
5-Bromo-2' -Deoxyuridine [BUDR, M.W. = 307.4]
Trial 1 [IP3]
B(a)P .000791 ND
B(a)P .000250 ND
BUDR .179
BUDR .0895
BUDR .0447
NC Control
30.1
41.2
75.7
100.
ND
ND
ND
100.
228 (20)
369 (20)
69 (20)
8 (40)
10.2***
17.4***
2.91***
.149
+ 12.2
+ 6.87
+ 3.25
+ 0.36
Control
Mean t = 5.67
+ 7.68
+ 7.74
+ 2.65
0.00 (-2.25)
0.00 (-0.36)
0.00 (-0.35)
Control
Mean t = .663
+ 20.7
+ 31.3
+ 9.56
Control
Mean t = 20.5
(Continued on nextpage)
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Table AL Continued
Cytotoxi c
Treatment Activityb Transforming Transformation
Conditiona RCE (%) Activityc Responsed
Focus Data Foci/Vessel
Type Vessels Focus Type Significancee
Drug Conc. mM S.A. CC.A. III (N) III t-statistic
Trial 2
B(a)P
B(a)P
[1P7]
.000791
.000250
ND
ND
MNNG .0170
BUDR .104
BUDR .052
BUDR .026
NC Control
Trial 3 [Exp. #95]
B(a)P .000791
B(a)P .000250
BUDR .130
BUDR .0976
BUDR .0651
BUDR .0325
NC Control
19.9 ND
12.5
78.3
80.9
100.
ND
ND
ND
ND
16.0 ND
33.3 ND
16.4
27.9
39.0
68.3
100.
ND
ND
ND
ND
ND
59 (15)
110 (15)
91 (15)
32 (15)
40 (30)
152 (20)
115 (20)
79
118
62
22
263
3.72**
6.40**
5.29**
1.66
.97
7.35***
5.27***
(19)
(19)
(17)
(17)
(77)
3.78
5.85***
2.87
1.08
2.84
+ 6.88
+ 7.87
+ 6.81
+ 1.61
Control
MEAN t = 5.43
+ 9.48
+ 3.42
+ 1.67
+ 6.00
+ 0.05
0.00 (-4.40)
Control
Mean t = 1.93
Carisoprodol [CARP, M.W. = 260.]
Trai1
B(a)P
B(a)P
1 [Exp. #46]
.000791
.000250
CARP 6.15
CARP 4.62
CARP 3.08
CARP 1.54
NC-1 Control
Trial 2 [Exp. #52]
B(a)P .000791
B(a)P .000250
5.52 35.7
22.4 81.1
.000
.000
41.7
75.5
100.
.000
.000
71.3
84.5
100.
4.04 39.8
11.1 75.4
127 (20)
75 (20)
6 (12,20)
4 (9,20)
7 (20)
24 (20)
24 (20)
150 (20)
126 (20)
6. 14***
3.32***
.381
.361
.275
.838
.384
6.63***
5.61***
+ 12.4
+ 8.63
0.00 (-0.02)
0.00 (-0.10)
0.00 (-0.67)
0.00 (-1.95)
Control
Mean t= .00
+ 9.35
+ 8.18
.562
1.26
1.60
2.14*
1.09
0.00 (-1.96)
+ 0.56
+ 1.43
+ 2.60
Control
Mean t = 1.53
Chloramphenicol Sodium Succinate [CHSU, M.W. 463.]
.357 57.9
3.21 88.2
9.26***
3.94***
CHSU 5.83
CHSU 3.89
CHSU 2.92
CHSU 1.94
NC Control
Trial 2 [Exp. #58]
B(a)P .000791
B(a)P .000250
.000
2.86
16.4
50.7
100.
60.6
42.2
64.7
104.
100.
3.92 34.3
14.7 60.6
8 (19)
5 (18)
3 (20)
8 (20)
22 (40)
128 (20)
71 (20)
.339
.212
.110
.275
.433
6. 17***
1 .83***
0.00 (-0.64)
0.00 (-1.57)
0.00 (-3.02)
0.00 (-1.07)
Control
Mean t = .000
+ 22.5
+ 4.78
(Continued on nextpage)
CARP
CARP
CARP
CARP
NC-1
4.00
2.00
1.00
.500
Control
6.40
47.8
77.8
94.6
100.
2.63
76.4
89.2
94.6
100.
13 (18)
29 (20)
34 (18)
55 (20)
55 (38)
Trial 1
B(a)P
B(a)P
[Exp. #49]
.000791
.000250
188 (19)
87 (20)
+ 18.5
+ 11.3
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Cytotoxi c
Treatment Activityb Transforming Transformation
Conditiona RCE (%) ActivityC Responsed
Focus Data Foci/Vessel
Type Vessels Focus Type Significance'
Drug Conc. mM S.A. CC.A. III (N) III t-statistic
CHSU 6.00 .000 52.2 10 (20) .414 + 1.97
CHSU 4.50 .327 94.4 6 (20) .214 + 0.23
CHSU 3.00 15.7 101. 2 (20) .072 0.00 (-1.37)
CHSU 1.50 65.0 86.8 4 (15) .203 + 0.12
NC Control 100. 100. 10 (40) .189 Control
Mean t = .580
4-Chloro-2-Nitroaniline [4C2NA, M.W. 172.5]
Trial 1 [Exp. #46]
B(a)P .00791 5.52 35.7 127 (20) 6.14*** + 12.4
B(a)P .00250 22.4 81.1 75 (20) 3.32*** + 8.63
4C2NA .870 .000 19.1 5 (20) .189 0.00 (-1.45)
4C2NA .652 23.8 59.5 9 (20) .320 0.00 (-0.37)
4C2NA .435 43.1 84.8 10 (20) .366 0.00 (-0.10)
4C2NA .217 65.1 91.7 11 (20) .423 + 0.21
NC Control 100. 100. 24 (40) .384 ControL
Mean t = .053
Trial 2 [Exp. #53]
B(a)P .00791 4.78 58.9 182 (20) 8.30*** + 7.68
B(a)P .00250 7.97 76.8 195 (20) 8.74*** + 7.74
4C2NA .580 13.5 67.7 48 (20) 2.21 0.00 (-1.49)
4C2NA .435 33.1 70.3 65 (20) 2.98 + 0.45
4C2NA .290 37.8 71.6 53 (20) 2.26 0.00 (-1.18)
4C2NA .145 56.2 83.9 50 (20) 1.98 0.00 (-1.71)
NC ControL 100. 100. 128 (40) 2.78 ControL
Mean t = .113
C. I. Acid Red 114 [CIAR114, M.W. 830.]
Trial 1 [Exp. #64]
B(a)P .000791 6.45 26.6 98 (20) 4.47*** + 12.7
B(a)P .000250 16.9 69.1 32 (20) 1.37*** + 5.13
CIAR114 .964 1.61 28.1 4 (20) .149 0.00 (-1.13)
CIAR114 .482 55.2 73.4 9 (20) .366 + 0.52
CIAR114 .241 87.9 81.3 13 (20) .503 + 1.28
CIAR114 .120 106. 92.1 21 (20) .665 + 1.67
NC Control 100. 100. 17 (40) .291 Control
Mean t = .868
Trial 2 [Exp. #69]
B(a)P .000791 1.72 50.1 63 (20) 2.67*** + 9.34
B(a)P .000250 11.3 68.1 33 (20) 1.17*** + 3.53
CIAR114 1.00 .000 30.9 5 (14) .255 0.00 (-0.23)
CIAR114 .500 33.3 90.1 9 (18) .370 + 0.58
CIAR114 .250 84.2 97.7 12 (12) .550 + 1.67
CIAR114 .125 93.8 95.4 9 (9) .347 + 0.43
NC Control 100. 100. 15 (40) .288 Control
Mean t = .670
C. I. Direct Blue 15 [DB15, M.W. 993.]
Trial 1 [Exp. #64]
B(a)P .000791 6.45 26.6 98 (20) 4.47*** + 12.7
B(a)P .000251 16.9 69.1 32 (20) 1.37*** + 5.13
DB15 3.52 .000 54.7 32 (19) 1.37*** + 4.74
DB15 1.76 1.21 76.3 56 (20) 2.28*** + 9.25
(Continued on nextpage)
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Table Al. Continued.
Cytotoxic
Treatment Activityb Transforming Transformation
Conditiona RCE (%) Activityc Responsed
Focus Data Foci/Vessel
Type Vessels Focus Type Significancee
Drug Conc. mM S.A. CC.A. III (N) III t-statistic
DB15 .881
DB15 .441
NC Control
Trial 2 [Exp. #69]
B(a)P .000791
B(a)P .000250
92.7
112.
100.
77.7
87.1
100.
1.72 50.1
11.3 68.3
41 (20)
21 (20)
17 (40)
1.62***
.844**
.291
2.67***
1.17**
63 (20)
33 (20)
+ 5.44
+ 2.99
Control
Mean t = 5.61
+ 9.34
+ 3.53
1.39***
1.43***
.737**
.588
.288
+ 5.61
+ 4.55
+ 2.82
+ 1.54
Control
Mean t = 3.64
C. I. Direct Blue 218 [DB218, M.W. = 1088.]
1 [Exp. #49]
.00791
.00250
.357 57.9
3.21 88.2
9.26***
3.94***
2.00
1.00
.500
.250
Control
2 [Exp. #58]
.000791
.000250
.500
.375
.250
.125
Control
.000
.000
1.79
58.9
100.
.000
1.38
4.13
67.5
100.
3.92 34.3
14.7 60.6
.000
5.23
66.7
90.5
100.
45.2
72.5
89.2
101.
100.
0 (0,20)
15 (20)
15 (20)
31 (20)
22 (40)
128 (20)
71 (20)
21 (20)
5 (20)
17 (20)
10 (20)
10 (40)
.000
.489
.443
1.26***
.433
6.17***
1.83***
.877***
.189
.726***
.374
.189
NA
+ 0.31
+ 0.05
+ 3.79
Control
Mean t = 1.38
+ 22.5
+ 4.78
+ 4.73
+ 0.00
+ 4.05
+ 1.53
Control
Mean t = 2.58
Trans-Cinnamylaldehyde [CINAL, M.W. 132.2, DENSITY = 1.05]
Trial 1 [Exp. #79]
B(a)P .000791
B(a)P .000250
22.7 79.6
39.3 94.2
279 (13)
241 (18)
20.8***
12.9***
+ 13.9
+ 9.34
CINAL
CINAL
CINAL
CINAL
NC
.0605
.0303
.0151
.00756
Control
Trial 2 [Exp. #94]
B(a)P .000791
B(a)P .000250
.000
.000
8.26
47.1
100.
75.7
100.
101.
105.
100.
.000 75.7
17.4 114.
430 (18)
62 (18)
79 (18)
67 (18)
430 (72)
23.6***
3.14
3.76
2.80
5.12
122 (18)
81 (18)
5 .92***
3.88***
+ 19.4
0.00
0.00
0.00
Control
Mean t = 4.85
+ 6.26
+ 4.08
0.00 (-,3.28)
+ 2.58
+ 4.07
+ 0.87
Control
Mean t = 2.51
(Continued on next page)
DB15
DB15
DB15
DB15
NC
3.52
2.64
1.76
.881
Control
.000
3.78
65.3
99.7
100.
47.1
51.5
65.4
85.0
100.
33 (20)
36 (20)
18 (20)
17 (20)
15 (40)
Trial
B(a)P
B(a)P
188 (19)
87 (20)
DB218
DB218
DB218
DB218
NC
Trial
B(a)P
B(a)P
DB218
DB218
DB218
DB218
NC
+ 18.5
+ 11.3
CINAL
CINAL
CINAL
CINAL
NC
.0756
.0567
.0378
.0189
Control
(-2.95)
(-1.81)
(-2.98)
.000
.000
.000
1.03
100.
.000
28.5
109.
101.
100.
2 (8,18)
72 (18)
62 (18)
39 (18)
150 (71)
.189
2.97*
3.13***
1.90
1.52
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Cytotoxi c
Treatment Activityb Transforming Transformation
Conditiona RCE (%) ActivityC Responsed
Focus Data Foci/Vessel
Type Vessels Focus Type Significance'
Drug Conc. mM S.A. CC.A. III (N) III t-statistic
2,6-Dinitrotoluene [26DNT, M.W. = 150.]
Trial
B(a)P
B(a)P
1 [Exp. #91]
.000791
.000250
28.9 73.6
58.1 89.9
60 (20)
14 (20)
2.00***
.503
+ 5.11
+ 1.31
26DNT 1.333
26DNT .667
26DNT .333
26DNT .167
NC Control
Trial 2 [Exp. #105]
B(a)P .000791
B(a)P .000250
26DNT 8.00
26DNT 4.00
26DNT 2.00
26DNT 1.00
NC Control
29.8
59.6
79.1
79.3
100.
84.4
87.8
92.1
94.2
100.
5.67 63.1
18.2 86.5
.000
.000
.000
1.21
100.
.000
.792
51.5
74.1
100.
6 (20)
5 (20)
3 (19)
4 (20)
31 (75)
59 (20)
40 (19)
0 (4,20)
0 (20)
10 (20)
9 (20)
58 (77)
.214
.149
.116
.149
.322
2.43***
1.93***
.000
.000
.354
.327
.581
0.00 (-0.94)
0.00 (-1.55)
0.00 (-1.93)
0.00 (-1.61)
Control
Mean t = .00
+ 6.70
+ 5.54
0.00 (-8.86)
0.00 (-8.86)
0.00 (-1.36)
0.00 (-1.56)
Control
Mean t = .00
Cytosine Arabinoside [ARAC. M.W. = 279.68]
Trial
B(a)P
B(a)P
1 [Exp. IP4]
.000791
.000250
ND
ND
ARAC .000322
ARAC .000161
ARAC .0000805
NC Control
Trial
B(a)P
B(a)P
2 [Exp. IP7]
.000791
.000250
MNNG .0170
ARAC .000358
ARAC .000113
ARAC .000358
NC Control
Trial
B(a)P
B(a)P
3 [Exp. #95]
.000791
.000250
.000
5.9
39.4
100.
ND
ND
ND
ND
206 (20)
263 (20)
170 (20)
16 (40)
9.66***
12.52**
6.83***
.278
+ 20.3
+ 23.5
+ 14.1
Control
Mean t = 19.3
Not Available
Not Available
19.9 ND
.4 ND
41.5 ND
97.4 ND
16.0 ND
33.3 ND
59 (15)
73 (15)
49 (15)
17 (15)
40 (30)
152 (20)
115 (20)
3.72***
4.45***
3.04***
1.02
.97
7.35***
5.27***
+ 6.88
+ 8.61
+ 4.69
+ 0.08
Control
Mean t = 4.46
+ 9.48
+ 3.82
3.35
3.73
5.46***
8.66***
2.84
+ 0.89
+ 1.59
+ 4.03
+ 7.30
Control
Mean t = 5.09
Diphenylnitrosamine [DPN, 198.22]
1 [Exp. #75]
.000791
.000250
7.10 66.5
28.4 85.4
6.35***
3. 10***
(Continued on nextpage)
ARAC
ARAC
ARAC
ARAC
NC
.00143
.000715
.000358
.000179
Control
.000
.000
.000
3.55
100.
ND
ND
ND
ND
ND
65 (17)
86 (20)
121 (20)
184 (20)
263 (77)
Trial
B(a)P
B(a)P
149 (20)
67 (20)
+ 10.9
+ 6.56
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Table AL ContinuedL
Cytotoxic
Treatment Activityb Transforming Transformation
Conditiona RCE (%) ActivityC Responsed
Focus Data Foci/Vessel
Type Vessels Focus Type Significance'
Drug Conc. mM S.A. CC.A. III (N) III t-statistic
.948
.631
.315
.158
Control
2 [Exp. #91]
.000791
.000250
.757
.568
.378
.189
Control
.000
.000
46.8
76.4
100.
.000
33.4
76.8
83.5
100.
28.9 73.6
58.1 89.9
.000
.000
8.36
62.6
100.
16 (20)
30 (20)
43 (19)
35 (20)
89 (78)
60 (20)
20 (20)
4.46
52.4
71.3
90.6
100.
11 (18)
3 (20)
12 (20)
17 (20)
31 (75)
.619
1.24
2.04***
1.44*
.882
2.00***
.503
.423
.110
.452
.644*
.322
0.00 (-1.22)
+ 1.38
+ 3.88
+ 2.04
Control
Mean t = 1.83
+ 5.11
+ 1.31
+ 0.73
0.00 (-2.04)
+ 0.99
+ 2.21
Control
Mean t = .983
Isobutyraldehyde [IBA, 72.1, Density = 0.794]
1 [Exp. #78]
.000791
.000250
8.09 60.6
14.9 84.2
116 (18)
184 (18)
6.11***
9.84***
+ 4.93
+ 9.74
IBA 3.85
IBA 2.89
IBA 1.93
IBA .964
NC Control
Trial 2
B(a)P
B(a)P
5.53
7.23
19.1
33.2
100.
[Exp. #106]
.000791
.000250
78.5
70.7
78.5
70.8
100.
119
62
42
103
296
24.8 56.9
40.7 77.9
(18)
(18)
(18)
(18)
(72)
6.45**
2.95
2.02
4.43
3.28
134 (18)
91 (18)
6.88***
4.53***
+ 6.53
0.00 (-0.52)
0.00 (-2.34)
+ 1.49
Control
Mean t = 2.11
+ 8.00
+ 5.56
IBA 3.85
IBA 2.89
IBA 1.93
IBA .964
NC Control
.000
.000
.000
9.79
100.
.000
10.3
55.1
54.0
100.
7 (18)
12 (18)
25 (18)
15 (18)
74 (43)
.240
.587
1.20
.671
1.30
0.00
0.00
0.00
0.00
Control
Mean t = .00
(-4.50)
(-3.08)
(-0.29)
(-2.04)
Manganese Sulfate-H20 [MNSU, M.W. = 169.01]
Trial
B(a)P
B(a)P
MNSU
MNSU
MNSU
MNSU
NC
Trial 2
B(a)P
B(a)P
MNSU
MNSU
MNSU
MNSU
NC t
1 [Exp. #49]
.00791
.00250
.272
.204
.136
.068
.357 57.9
3.21 88.2
.000
2.86
11.5
61.8
100.
[Exp. #57]
.000791
.000250
.272
.204
.136
.0680
Control
24.3
41.9
58.8
78.1
100.
3.55 30.1
5.32 69.9
.000
.000
5.67
57.4
100.
188 (19)
87 (20)
28 (20)
35 (20)
55 (20)
22 (20)
22 (40)
162 (20)
37 (20)
1.81
13.8
60.0
84.4
100.
20 (19)
24 (20)
21 (18)
19 (20)
15 (40)
9.26***
3.94***
1. 10**
1 .50***
2.37***
.872*
.433
7.55***
1.63***
.804**
.892**
.918**
.692*
.278
+ 18.5
+ 11.3
+ 3.18
+ 4.89
+ 7.34
+ 2.24
Control
Mean t = 4.41
+ 18.7
+ 6.91
+ 2.92
+ 2.84
+ 3.85
+ 2.41
Control
Mean t = 3.03
(Continued on nextpage)
DPN
DPN
DPN
DPN
NC
Trial
B(a)P
B(a)P
DPN
DPN
DPN
DPN
NC
Trail
B(a)P
B(a)P
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Cytotoxic
Treatment Activityb Transforming Transformation
Conditiona RCE (%) Activityc Responsed
Focus Data Foci/Vessel
Type Vessels Focus Type Significance"
Drug Conc. mM S.A. CC.A. III (N) III t-statistic
2-Mercaptobenzimidazole [2MBZ, M.W. = 150.]
Trial 1 [Exp. #47]
B(a)P .000791 .351 28.1 173 (20) 8.10*** + 14.6
B(a)P .000250 7.72 75.6 88 (20) 3.89*** + 8.73
2MBZ 5.00 81.4 .000 27 (20) 1.11* + 2.20
2MBZ 3.75 82.1 9.76 45 (20) 2.04*** + 5.36
2MBZ 2.50 103. 78.1 60 (20) 1.77** + 2.82
2MBZ 1.25 95.8 99.0 40 (20) .869 + 0.90
NC Control 100. 100. 31 (39) .579 Control
Mean t = 2.82
Trial 2 Exp. #56]
B(a)P .000791 2.55 32.7 122 (20) 5.54*** + 16.5
B(a)P .000250 2.19 61.0 33 (20) 1.47*** + 6.97
2MBZ 4.0 1.09 28.0 27 (20) 1.09*** + 3.91
2MBZ 3.0 38.0 58.2 40 (20) 1.41*** + 4.23
2MBZ 2.0 57.3 79.6 14 (19) .583* + 2.21
2MBZ 1.0 65.4 86.8 9 (20) .347 + 0.69
NC Control 100. 100. 13 (39) .260 Control
Mean t = 2.76
Methdilazine-HCl [MEDL, M.W. = 296.]
Trial 1 [Exp. #47]
B(a)P .000791 .351 28.1 173 (20) 8.10*** + 14.6
B(a)P .000250 7.72 75.6 88 (20) 3.89*** + 8.73
MEDL .0541 .000 .000 0 (1,20) .000 0.00 (-0.95)
MEDL .0405 .000 15.6 8 (20) .256 0.00 (-1.81)
MEDL .0270 33.7 90.9 12 (20) .452 0.00 (-0.66)
MEDL .0135 77.9 99.2 7 (20) .275 0.00 (-1.80)
NC Control 100. 100. 31 (39) .579 Control
Mean t= .00
Trial 2 [Exp. #55]
B(a)P .000791 2.26 23.9 133 (20) 5.49*** + 15.2
B(a)P .000250 4.07 62.4 48 (20) 1.88*** + 7.12
MEDL .0507 .000 .784 0 (2,20) .000 0.00 (-2.88)
MEDL .0380 1.81 41.2 9 (20) .347 + 2.08
MEDL .0253 53.8 70.6 5 (20) .189 + 0.68
MEDL .0127 62.0 89.0 6 (20) .214 + 0.89
NC Control 100. 100. 7 (40) .129 Control
Mean t = 1.22
Mezerein [MEZ, M.W. = 654.]
Trial 1 [Exp. #59]
B(a)P .000791 1.35 36.5 165 (20) 7.31*** + 17.9
B(a)P .000250 7.41 74.3 33 (19) 1.34*** + 4.28
MEZ .0245 .000 71.9 29 (20) 1.18*** + 4.01
MEZ .0183 40.7 104. 50 (20) 2.22*** + 9.05
MEZ .0122 84.2 112. 140 (20) 6.33*** + 17.0
MEZ .0061 96.0 104. 228 (20) 11.0*** + 25.7
NC Control 100. 100. 15 (40) .297 Control
Mean t = 13.9
Trial 2 [Exp. #95]
B(a)P .000791 16.0 ND 152 (20) 7.35*** + 9.48
B(a)P .000250 33.2 ND 115 (20) 5.27*** + 3.82
(Continued on nextpage)
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Cytotoxi c
Treatment Activityb Transforming Transformation
Conditiona RCE (%) Activityc Responsed
Focus Data Foci/Vessel
Type Vessels Focus Type Significance'
Drug Conc. mM S.A. CC.A. III (N) III t-statistic
MEZ .0245
MEZ .0122
MEZ .00610
MEZ .00305
NC Control
.000
59.9
96.2
99.3
100.
ND
ND
ND
ND
ND
0
128
256
201
263
(0,20)
(16)
(17)
(15)
(77)
.000
7.45***
14.9***
12.9***
2.84
ND
+ 5.63
+ 20.3
+ 13.5
Control
Mean t = 13.1
Mono(2-ethylhexyl )adipate [M2EHA, M.W. = 258.42]
Trial 1 [Exp. #82]
B(a)P .000791
B(a)P .000250
46.8 47.2
56.3 51.6
371 (18)
288 (18)
19.4***
15.5***
M2EHA
M2EHA
M2EHA
M2EHA
NC
2.32
1.16
.580
.290
Control
.000
8.45
62.4
75.0
100.
Trial 2 [Exp. #94]
B(a)P .000791
B(a)P .000250
.000
49.0
92.3
98.0
100.
.000 75.7
17.4 114.
1
229
146
146
649
(5,18)
(18)
(18)
(18)
(72)
122 (18)
81 (18)
.149
11.9**
7.39
7.80
8.01
5.92***
3.88***
0.00 (-10.4)
+ 3.25
0.00 (-0.63)
0.00 (-0.22)
Control
Mean t = 1.08
+ 6.26
+ 4.08
1 (11,18)
6 (18)
5 (18)
22 (9)
150 (71)
0.00 (-8.76)
0.00 (-6.18)
0.00 (-6.56)
+ 0.38
Control
Mean t = .127
Mono(2-ethylhexyl)phthalate [M2EHP. M.W. = 278.38]
Trial 1 [Exp. #79]
B(a)P .000791
B(a)P .000250
279 (13)
241 (18)
20.8***
12.9***
M2EHP
M2EHP
M2EHP
M2EHP
NC
1.44
1.08
.718
.359
Control
.000
2.48
74.4
113.
100.
Trial 2 [Exp. #84]
B(a)P .000791
B(a)P .000250
M2EHP
M2EHP
M2EHP
M2EHP
NC
1.44
1.08
.718
.359
Control
.811
27.4
95.5
95.8
100.
53
249
110
49
430
.000 75.7
17.4 114.
1.0
54.4
85.1
126.
100.
23.6
64.6
76.2
89.7
100.
(15,18)
(18)
(18)
(18)
(72)
122 (18)
81 (18)
2.42
13.3***
5.24
2.42
5.12
5 .92***
3.88***
30 (18)
43 (18)
52 (18)
76 (18)
150 (71)
1.11
1.72
2.24
3.35**
1.52
0.00 (-2.72)
+ 9.16
+ 0.14
0.00 (-4.33)
Control
Mean t = 3.05
+ 6.26
+ 4.08
0.00 (-1.07)
+ 0.44
+ 1.48
+ 3.31
Control
Mean t = 1.31
Riddelliine [RIDL, M.W. = 349.]
Trial 1 [Exp. #48]
B(a)P .00791
B(a)P .00250
2.28 47.9
10.1 90.8
148 (20)
63 (20)
7.06***
2.68***
+ 16.5
-- 6.53
(Continued on nextpage)
+ 7.45
+ 7.97
M2EHA
M2EHA
M2EHA
M2EHA
NC
1.93
1.45
.967
.484
Control
.000
.000
.000
.000
100.
.000
22.7
56.4
96.5
100.
.065
.240
.136
1.75
1.52
22.7 79.6
39.3 94.2
+ 13.9
+ 9.34
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Table AL Continued
Cytotoxic
Treatment Activityb Transforming Transformation
Conditiona RCE (%) ActivityC Responsed
Focus Data Foci/Vessel
Type Vessels Focus Type Significance'
Drug Conc.,M S.A. CC.A. III (N) III t-statistic
2.579
1.289
.645
.322
Control
2 [Exp. #66]
.000791
.000250
3.00
1.50
.750
.375
Control
9.77 62.0
39.7 83.0
71.0 95.3
89.3 88.3
100. 100.
2.33 52.0
6.08 98.4
1.01
7.09
34.1
51.0
100.
79 (20)
41 (20)
34 (19)
29 (20)
29 (40)
90 (20)
24 (20)
21 (20)
4 (20)
2 (18)
7 (18)
3 (38)
77.0
93.7
100.
103.
100.
3.19***
1 .78***
1 .22*
.948
.537
3.92***
.795**
.824**
.132
.080
.227
.056
+ 7.36
+ 4.58
+ 2.40
+ 1.77
Control
Mean t = 4.03
+ 14.1
+ 3.69
+ 4.68
+ 0.91
+ 0.39
+ 1.39
Control
Mean t = 1.84
Sodium Fluoride [also 300509-S, M.W. = 40.]
Trial 1 [Exp. #70]
B(a)P .000791
B(a)P .000250
1.24 48.9
11.8 81.0
11 (3)
19 (5)
3.38***
3.62***
+ 4.23
+ 5.73
300509-S
300509-S
300509-S
300509-S
NC
4.50
3.38
2.25
1.13
Control
Trial 2 [Exp. #101]
B(a)P .000791
B(a)P .000250
300509-S 4.00
300509-S 3.00
300509-S 2.00
300509-S 1.00
NC Control
2.48
3.11
3.11
35.4
100.
1.93
9.32
53.4
96.1
100.
ND 64.8
ND 83.6
ND
ND
ND
ND
100.
21.8
50.3
87.7
104.
100.
7 (19)
9 (18)
9 (20)
9 (16)
36 (54)
108 (20)
48 (20)
23 (17)
12 (13)
7 (16)
9 (20)
27 (78)
.272
.339
.320
.274
.526
4.63***
2.11***
1 .06**
.682
.330
.347
.260
0.00 (-1.67)
0.00 (-1.12)
0.00 (-1.33)
0.00 (-1.400
Control
Mean t = .000
+ 12.7
+ 9.73
+ 3.51
+ 1.87
+ 0.56
+ 0.75
Control
Mean t = 1.67
12-0-TetradecanoylPhorbol-13-Acetate [TPA, M.W. = 616]
Trial 1 [Exp. #70]
B(a)P .000791
B(a)P .000250
1.24 48.9
11.8 81.0
.0227
.0170
.0114
.0057
Control
2 [Exp. #105]
.000791
.000250
.000
.000
57.8
87.0
100.
.000
2.57
83.6
86.5
100.
5.67 63.1
18.2 86.5
0 (0,13)
0 (2,14)
8 (16)
5 (15)
36 (54)
59 (20)
40 (19)
.000
.000
.389
.260
.526
2.43***
1 .93***
NA
0.00 (-7.39)
0.00 (-0.80)
0.00 (-1.62)
Control
Mean t = .000
+ 6.70
+ 5.54
TPA .0195
TPA .0146
TPA .00974
TPA .00487
NC Control
.000
2.83
63.6
79.4
100.
.000
28.0
90.8
93.7
100.
0 (0,20)
7 (17)
7 (18)
10 (18)
58 (77)
.000
.256
.289
.392
.581
NA
0.00 (-1.55)
0.00 (-1.77)
0.00 (-1.07)
Control
Mean t = .000
(Continued on nextpage)
RIDL
RIDL
RIDL
RIDL
NC
Trial
B(a)P
B(a)P
RIDL
RIDL
RIDL
RIDL
NC
11 (3)
19 (5)
TPA
TPA
TPA
TPA
NC
Trial
B(a)P
B(a)P
3.38***
3.62***
+ 4.23
+ 5.73
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Tnbe ALContinued.
Cytotoxic
Treatmet Activity Transforming Transformtion
co itioa KCE (%) AtivityC Response'
Focus Data Foci/Vessel
Type Vessels Focus Type Significance
Drug Conc. 1 S.A. CC.A. III (N) III t-statistic
2,6-Xylidine [26XY, M.W. = 121.18, Density= 0.98]
Trial 1 [Exp. #84]
B(a)P .000791 49.8 57.9 71 (18) 3.27*** + 6.82
B(a)P .000250 ND 71.7 57 (18) 2.44*** + 6.14
26XY 8.09 .000 .000 1 (6,18) .122 .00 (-1.52)
26XY 6.07 20.5 50.9 25 (18) 1.20** + 3.09
26XY 4.04 43.2 80.0 19 (18) .823 + 1.52
26XY 2.06 63.7 92.8 18 (18) .805 + 1.44
NC Control 100. 100. 50 (72) .511 Control
Mean t = 2.02
Trial 2 [Exp. #100]
B(a)P .000791 89.7 77.9 65 (18) 3.30*** + 11.7
B(a)P .000250 81.0 93.8 62 (18) 2.85*** + 7.75
26XY 8.09 .000 9.55 2 (6,18) .260 0.00 (-0.040
26XY 6.07 .000 48.6 18 (18) .661 + 1.82
26XY 4.04 .920 76.4 21 (18) .901*** + 3.59
26XY 2.06 23.4 98.9 16 (18) .687** + 2.62
NC ControL 100. 100. 28 (72) .268 Control
Mean t = 2.68
Abbreviations: B(a)P, benzo(a)pyrene; CC.A., co-culture clonal survival assay; Conc., concentration; mM, millimole; M.W., molecular weight; N,
number ofculture vessels; NC, negative control; %RCE, percent relative cloning efficiency; S.A, standard clonal survival assay; ND, not determined.
'IfreatmentCondition:Theexperimentaldesignforthetransformation assayisdescribedindetailintheMaterialsandMethods.Theconcentrationof
thepositive control and testchemical treatment arepresented in mM, buttheycan be converted to tLg/mL usingthe molecularweightthatis provided
with each chemical. The solventvehicles used for the individual test chemicalswere listed in Table 1, and the concentrations ofthe solventvehicles are
presented in the Materials and Methods.
bCytotoxicActivity:Theexperimentaldesignforthestandardclonalsurvivalassayandtheco-cultureclonalsurvivalassayweredescribedindetailin
the Materials and Methods. The test chemical cytotoxic response was expressed as % RCE and was calculated as described in the Materials and
Methods.
cTransforming Activity: The criteria used to evaluate the transformed foci of BALB/c-3T3 cells is described in the Materials and Methods. The
number oftype III foci > 2-mm in diameter per culture vessel scored are recorded in this table.
d'Transformation Response: The transformation responses are expressed as type III foci/vessel and were calculated using a log1o mathematical
transformation procedure(refertoMaterialsandMethods).Thearithmeticvalueorfoci/vesselrepresentstheantilogofthelog1omeantransformation
response minus one.
eSignificance: The significance oftestchemical transformation responseswere calculatedby acomputerusingthe SAS statistical software(25), and
themethod is described in detail in Materials and Methods. The correct t-statistic according to the F-testis presented in this table. The t-statistics of
each treatmentdoseofthe testchemical in asingleexperimentwere averaged to determine themeant-statistic ofthe testchemicalfortheexperiment
(refertoTable2).Themeant-statisticfortwoorexperimentsforeachchemicalwasweighted accordingtothenumberoftreatmentdosesevaluatedand
averaged to determine the rank t-statistic which was used to rank-order the test chemical transformation responses in Table 3. Arbitrarily,
transformation responses with negative (-) t-statistics were given avalue ofzero (0).
*Significant BaP or test chemical transformation response, 0.01 < p < 0.05.
**Significant BaP ortest chemical transformation response, 0.001 < p < 0.01.
***Significant BaP or test chemical transformation response, p < 0.001.
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Appendix B.
Table Al. Comparison oftransformation responses ofcoded chemicals detected in assays conducted using two different assay protocolsa
Thansformation Response'
Chemicalb id Ie
Chemicals Active in Protocol II
1I-aminoundecanoic acid - SN ++ LN,LN,SP,SP
allyl isothiocyanate - SN ++ LA,SP
barium chloride-2H20 - SN ++ SP,LA
benzidine-2HCI - SN ++ SP,SP
2-biphenylamine - SN ++ SP,SP
4-biphenylamine - SN ++ SP,LA
4-chloro-o-toluidine-HCI - SN ++ LN,SP,SP
C.I. direct blue 15 - SN ++ SP,SP
cinnamaldehyde - SN ++ LA,SP
C.I. solvent yellow 14 - SN ++ SP,SP,LA,SP
D&C red 9 - SN ++ SP,LA,SP
2,6-dichloro-p-phenylenediamine + SP ++ SP,SP
diglycidyl resorcinol ether - LA ++ SP,SP
epichlorohydrin - SN ++ LA,SP
ethylene thiourea - SN + LN,SP
FD & C yellow no. 6 - LA ++ SP,SP,SP
H.C. red 3 - SN ++ SP,SP,LA,SP
manganese sulfate-H20 - SN ++ SP,SP
melamine - SN ++ SP,LA
melphalan + SP ++ LA,SP
2-mercaptobenzimidazole - SN ++ SP,SP
methyl carbamate - SN ++ SP,LA,SP,SP,SP
4,4-methylenedianiline-2HCI - SN ++ SP,SP
2-naphthylamine - SN ++ SP,SP
diethanolnitrosamine ND + SP
4,4-oxydianiline - LA ++ SP,SP
polybrominated biphenyl mixture - LA ++ SP,SP
riddelliine + SN,SP ++ SP,LA
2,6-xylidine - SN ++ LA,SP
Chemicals Inactive in Protocol II
benzoin
bisphenol A
caprolactam
carisoprodol
chloramphenicol sodium succinate
4-chloro-2-nitroaniline
C.I. acid orange 10
C.I. acid red 114
C.I. basic red 9
C.I. direct blue 218
cinnamyl anthranilate
dichlorvos
2,4-dinitrotoluene
diphenylhydantoin
geranyl acetate
H.C. blue I
8-hydroxyquinoline
isobutyraldehyde
methapyrilene-HCI
methdilazine-HCI
- SN
SN
SN
SN
SN
NA
- SN
- SN
- SN
+ SP
NA
- SN
SN,SN
SN
SN,SN
SN
SN
SN
SN
ND
SN,SN
qNT A RN MN
- J SN,SN
- SN,SN
- SN,SN
- SN,SN
- SN,SN
- SN,SN
- SN,SN,SNS
E LA,LA
- SN,SN,SN
- SN,LA,SN,SN,SP
- SN,SN,SN
- SN,SN
- SN,SN
E SN,SN,SP
E SP,SN,SN
- LA,SN
- SN,SN,SN
- SN,SN
|,SN,SN
(Continued on nextpage)
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Table AL. Continued.
Transformation Responsec
Chemicalb Id IIe
methylphenidate-HCI - SN - SN,SN
molybdenum trioxide - SN - LA,SN
mono(2-ethylhexyl)adipate - SN - LA,SN
mono(2-ethylhexyl)phthalate - LA E LA,LA
reserpine - SN - LA,SN,SN
tetrahydrofuran - LA - SN,LA
Abbreviations forChemicalTransformation ResponseinIndividualExperiments: SP, sufficientpositive; LA,limitedactivity; SN, sufficientnegative;
LN, limited negative; ND, not determined.
Abbreviations for Overall Chemical Transformation Response: + +, active; +, weakly active; -, inactive; E, equivocal activity.
aProtocols: The information contained in this table have been previously discussed in a poster presentation (10). The data summarize the results of
testing chemicals in two different BALB/c-3T3 cell transformation assay protocols, including: 1) Protocol I which was used on a interagency contract
with the EPAandthe NIEHS [NIEHS Contract No. 68-02-3682[, and 2) Protocol II which used in this investigation (12,16-18) [NIEHS Contract No.
NO1-ES-65150].
bChemical: Atotalof59codedchemicalswerefurnishedtobetestedusingProtocolI;however,datawasobtainedforonly55ofthesechemicals.All59
chemicals were retested in the current investigation and these data are reported in detail in either this paper or in part V (12).
`Iransformation Response:Thistablepresentsasummaryofthetransformation responsesdetectedforchemicalstestedinoneormoreexperiments
using either Protocol I or Protocol II. The method used to call individual experiments, as well as two or experiments, is described in detail in the
Materials and Methods.
dProtocol I: The majorprocedural differences between protocols I versus II which enhanced the sensitivity ofProtocol II, included: treatment time
duration [72versus 48hours]; initiation ofchemicaltreatments [day1-4versusday2-4]; seedingdensity[1 x 104versus 3.2 x 104cells/vessel];number
oftreated cells/dose [- 3 x 104/20 vessels versus 10 x 104 cells/20 vessels]; method used to select test chemical treatment doses [standard clonal
survival assay (Materials and Methods) versus co-culture clonal survival assay (17)]; FBS concentration in maintenance medium [5.0% versus 7.5%];
and solventvehicles [DMSO and acetone versus organic solvent and pluronic F68 (refer to Materials and Methods)].
Other differences between Protocols I versus II included: experimental trials/chemical [1 versus 2 ormore]; treatment doses/chemical [5 versus 4];
numberofchemicals/experiment [1 or2versus3to6]; positivecontrol [MCAversus B(a)P]; andtypeoffociscored [type IIIversustypes I, IIand III].
eProtocol II: The methods used in Protocol II are described in Materials and Methods.
345